WO2009009064A1 - Ultrasound coupling material - Google Patents
Ultrasound coupling material Download PDFInfo
- Publication number
- WO2009009064A1 WO2009009064A1 PCT/US2008/008414 US2008008414W WO2009009064A1 WO 2009009064 A1 WO2009009064 A1 WO 2009009064A1 US 2008008414 W US2008008414 W US 2008008414W WO 2009009064 A1 WO2009009064 A1 WO 2009009064A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ultrasound coupling
- coupling material
- ultrasound
- hydrogel
- hydrating fluid
- Prior art date
Links
- 238000002604 ultrasonography Methods 0.000 title claims abstract description 262
- 239000000463 material Substances 0.000 title claims abstract description 233
- 230000008878 coupling Effects 0.000 title claims abstract description 220
- 238000010168 coupling process Methods 0.000 title claims abstract description 220
- 238000005859 coupling reaction Methods 0.000 title claims abstract description 220
- 239000000017 hydrogel Substances 0.000 claims abstract description 156
- 239000012530 fluid Substances 0.000 claims abstract description 112
- 230000000887 hydrating effect Effects 0.000 claims abstract description 104
- 239000007787 solid Substances 0.000 claims abstract description 43
- 239000003795 chemical substances by application Substances 0.000 claims description 87
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 56
- 229920000642 polymer Polymers 0.000 claims description 39
- 239000004094 surface-active agent Substances 0.000 claims description 30
- 239000002253 acid Substances 0.000 claims description 26
- 150000002500 ions Chemical class 0.000 claims description 26
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 24
- 229920002401 polyacrylamide Polymers 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 17
- 229920002125 Sokalan® Polymers 0.000 claims description 13
- 210000000481 breast Anatomy 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 13
- 239000011575 calcium Substances 0.000 claims description 12
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 12
- 239000000080 wetting agent Substances 0.000 claims description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 11
- 229910052791 calcium Inorganic materials 0.000 claims description 11
- 229920006037 cross link polymer Polymers 0.000 claims description 11
- 239000004584 polyacrylic acid Substances 0.000 claims description 11
- 239000002202 Polyethylene glycol Substances 0.000 claims description 10
- 159000000007 calcium salts Chemical class 0.000 claims description 10
- 229920001223 polyethylene glycol Polymers 0.000 claims description 10
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 239000002245 particle Substances 0.000 claims description 9
- 235000010443 alginic acid Nutrition 0.000 claims description 8
- 229920000615 alginic acid Polymers 0.000 claims description 8
- 229920001577 copolymer Polymers 0.000 claims description 8
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 7
- 239000003755 preservative agent Substances 0.000 claims description 7
- 235000010413 sodium alginate Nutrition 0.000 claims description 7
- 239000000661 sodium alginate Substances 0.000 claims description 7
- 229940005550 sodium alginate Drugs 0.000 claims description 7
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 6
- 229940072056 alginate Drugs 0.000 claims description 6
- 238000004891 communication Methods 0.000 claims description 6
- 239000011148 porous material Substances 0.000 claims description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 5
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 claims description 5
- 229920002674 hyaluronan Polymers 0.000 claims description 5
- 229960003160 hyaluronic acid Drugs 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 4
- 235000019700 dicalcium phosphate Nutrition 0.000 claims description 4
- 239000004816 latex Substances 0.000 claims description 4
- 229920000126 latex Polymers 0.000 claims description 4
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims description 4
- 229940048086 sodium pyrophosphate Drugs 0.000 claims description 4
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims description 4
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims description 4
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 235000011132 calcium sulphate Nutrition 0.000 claims description 2
- 239000007822 coupling agent Substances 0.000 claims 18
- 150000004676 glycans Chemical class 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 description 26
- -1 calcium Chemical class 0.000 description 25
- 239000000203 mixture Substances 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 238000000034 method Methods 0.000 description 19
- 238000012360 testing method Methods 0.000 description 15
- 230000036571 hydration Effects 0.000 description 13
- 238000006703 hydration reaction Methods 0.000 description 13
- 238000009472 formulation Methods 0.000 description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 9
- 238000005187 foaming Methods 0.000 description 9
- 239000003361 porogen Substances 0.000 description 9
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 8
- 239000003352 sequestering agent Substances 0.000 description 8
- 150000007513 acids Chemical class 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 210000004872 soft tissue Anatomy 0.000 description 6
- 238000012285 ultrasound imaging Methods 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 238000013101 initial test Methods 0.000 description 5
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 5
- 229920001059 synthetic polymer Polymers 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 4
- 238000003491 array Methods 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000004971 Cross linker Substances 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229920001400 block copolymer Polymers 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000005022 packaging material Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 229920002627 poly(phosphazenes) Polymers 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- 229940068984 polyvinyl alcohol Drugs 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 2
- 235000007119 Ananas comosus Nutrition 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical group [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical group [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- 235000011430 Malus pumila Nutrition 0.000 description 2
- 235000015103 Malus silvestris Nutrition 0.000 description 2
- OKJIRPAQVSHGFK-UHFFFAOYSA-N N-acetylglycine Chemical compound CC(=O)NCC(O)=O OKJIRPAQVSHGFK-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 125000003277 amino group Chemical class 0.000 description 2
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- AYJRCSIUFZENHW-UHFFFAOYSA-L barium carbonate Chemical compound [Ba+2].[O-]C([O-])=O AYJRCSIUFZENHW-UHFFFAOYSA-L 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- NLSCHDZTHVNDCP-UHFFFAOYSA-N caesium nitrate Chemical compound [Cs+].[O-][N+]([O-])=O NLSCHDZTHVNDCP-UHFFFAOYSA-N 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 229920002678 cellulose Chemical class 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 238000002144 chemical decomposition reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011067 equilibration Methods 0.000 description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 2
- 150000002222 fluorine compounds Chemical group 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical group I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- DCEMCPAKSGRHCN-UHFFFAOYSA-N oxirane-2,3-dicarboxylic acid Chemical compound OC(=O)C1OC1C(O)=O DCEMCPAKSGRHCN-UHFFFAOYSA-N 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical class S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- 210000001685 thyroid gland Anatomy 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- WDYRPTWUNMHTJL-UHFFFAOYSA-N 2-(carboxymethylsulfonyl)acetic acid Chemical compound OC(=O)CS(=O)(=O)CC(O)=O WDYRPTWUNMHTJL-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
- OEOIWYCWCDBOPA-UHFFFAOYSA-N 6-methyl-heptanoic acid Chemical compound CC(C)CCCCC(O)=O OEOIWYCWCDBOPA-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 244000208874 Althaea officinalis Species 0.000 description 1
- 235000006576 Althaea officinalis Nutrition 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 240000000662 Anethum graveolens Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- ONAIRGOTKJCYEY-XXDXYRHBSA-N CCCCCCCCCCCCCCCCCC(O)=O.O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ONAIRGOTKJCYEY-XXDXYRHBSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 235000016795 Cola Nutrition 0.000 description 1
- 235000011824 Cola pachycarpa Nutrition 0.000 description 1
- 241000949463 Correa reflexa Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 240000006550 Lantana camara Species 0.000 description 1
- 235000013628 Lantana involucrata Nutrition 0.000 description 1
- 240000005183 Lantana involucrata Species 0.000 description 1
- 244000165082 Lavanda vera Species 0.000 description 1
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 1
- 240000003483 Leersia hexandra Species 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 1
- 240000005561 Musa balbisiana Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 229920000463 Poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) Polymers 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 239000004113 Sepiolite Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000004338 Syringa vulgaris Nutrition 0.000 description 1
- 244000297179 Syringa vulgaris Species 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229910010280 TiOH Inorganic materials 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 229920002310 Welan gum Polymers 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241000482268 Zea mays subsp. mays Species 0.000 description 1
- STYIACQTBAUJLY-UHFFFAOYSA-N [Co+3].[Ir+4] Chemical compound [Co+3].[Ir+4] STYIACQTBAUJLY-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910001420 alkaline earth metal ion Inorganic materials 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003254 anti-foaming effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 235000013549 apple pie Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 238000000222 aromatherapy Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229960000892 attapulgite Drugs 0.000 description 1
- 159000000009 barium salts Chemical class 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 235000010634 bubble gum Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 229920001525 carrageenan Chemical class 0.000 description 1
- 239000000679 carrageenan Chemical class 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000001913 cellulose Chemical class 0.000 description 1
- 159000000006 cesium salts Chemical class 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- BFGKITSFLPAWGI-UHFFFAOYSA-N chromium(3+) Chemical compound [Cr+3] BFGKITSFLPAWGI-UHFFFAOYSA-N 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940071160 cocoate Drugs 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 229920006237 degradable polymer Polymers 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- CURUTKGFNZGFSE-UHFFFAOYSA-N dicyclomine Chemical group C1CCCCC1C1(C(=O)OCCN(CC)CC)CCCCC1 CURUTKGFNZGFSE-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical compound [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960003082 galactose Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 235000012432 gingerbread Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 229940071264 lithium citrate Drugs 0.000 description 1
- WJSIUCDMWSDDCE-UHFFFAOYSA-K lithium citrate (anhydrous) Chemical compound [Li+].[Li+].[Li+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WJSIUCDMWSDDCE-UHFFFAOYSA-K 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- INHCSSUBVCNVSK-UHFFFAOYSA-L lithium sulfate Inorganic materials [Li+].[Li+].[O-]S([O-])(=O)=O INHCSSUBVCNVSK-UHFFFAOYSA-L 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- MMIPFLVOWGHZQD-UHFFFAOYSA-N manganese(3+) Chemical compound [Mn+3] MMIPFLVOWGHZQD-UHFFFAOYSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 229940041290 mannose Drugs 0.000 description 1
- 235000001035 marshmallow Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 238000005459 micromachining Methods 0.000 description 1
- 150000002772 monosaccharides Chemical group 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229910052625 palygorskite Inorganic materials 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000021400 peanut butter Nutrition 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 125000002467 phosphate group Chemical class [H]OP(=O)(O[H])O[*] 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002717 polyvinylpyridine Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 229940107700 pyruvic acid Drugs 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 235000021572 root beer Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229910052624 sepiolite Inorganic materials 0.000 description 1
- 235000019355 sepiolite Nutrition 0.000 description 1
- 239000012781 shape memory material Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- JDVPQXZIJDEHAN-UHFFFAOYSA-N succinamic acid Chemical compound NC(=O)CCC(O)=O JDVPQXZIJDEHAN-UHFFFAOYSA-N 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- RBTVSNLYYIMMKS-UHFFFAOYSA-N tert-butyl 3-aminoazetidine-1-carboxylate;hydrochloride Chemical compound Cl.CC(C)(C)OC(=O)N1CC(N)C1 RBTVSNLYYIMMKS-UHFFFAOYSA-N 0.000 description 1
- UVZICZIVKIMRNE-UHFFFAOYSA-N thiodiacetic acid Chemical compound OC(=O)CSCC(O)=O UVZICZIVKIMRNE-UHFFFAOYSA-N 0.000 description 1
- CMWCOKOTCLFJOP-UHFFFAOYSA-N titanium(3+) Chemical compound [Ti+3] CMWCOKOTCLFJOP-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical class [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B17/225—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves
- A61B17/2251—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves characterised by coupling elements between the apparatus, e.g. shock wave apparatus or locating means, and the patient, e.g. details of bags, pressure control of bag on patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Clinical applications
- A61B8/0825—Clinical applications for diagnosis of the breast, e.g. mammography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/42—Details of probe positioning or probe attachment to the patient
- A61B8/4272—Details of probe positioning or probe attachment to the patient involving the acoustic interface between the transducer and the tissue
- A61B8/4281—Details of probe positioning or probe attachment to the patient involving the acoustic interface between the transducer and the tissue characterised by sound-transmitting media or devices for coupling the transducer to the tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
- A61B17/225—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves
- A61B17/2251—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves characterised by coupling elements between the apparatus, e.g. shock wave apparatus or locating means, and the patient, e.g. details of bags, pressure control of bag on patient
- A61B2017/2253—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves characterised by coupling elements between the apparatus, e.g. shock wave apparatus or locating means, and the patient, e.g. details of bags, pressure control of bag on patient using a coupling gel or liquid
Definitions
- the present invention is generally directed to ultrasound coupling materials.
- the present invention is directed to ultrasound coupling materials that include at least one hydrogel, a viscosifying agent or a combination thereof and a hydrating fluid, wherein the hydrating fluid is introduced to the hydrogel, viscosifying agent or combination thereof to form a semi-solid ultrasound coupling material that does not compromise the image quality of the tissue being imaged or distort the tissue being imaged and minimizes patient discomfort since it can be easily removed and/or disposed of.
- Ultrasound is a non-invasive means of imaging internal soft tissue and soft tissue structures, such as the gallbladder, liver, heart, kidneys, pancreas, bladder, thyroid gland, prostate, uterus and breast tissue.
- Ultrasound imaging can help in the diagnosis of a wide range of diseases and conditions. For example ultrasound can help detect breast cancer and measure the flow of blood in arteries to detect blockages. Ultrasound can also be used to monitor the growth and development of embryos in the uterus.
- high-frequency sound waves inaudible to the human ear, are transmitted through body tissues using an instrument called a transducer. The ultrasound waves are used to detect variations in tissue densities.
- the transducer then transmits the information to a computer that displays the information on a monitor.
- the transducer Since the ultrasound waves are poorly transmitted through air, the transducer is generally placed in direct contact with the patient's skin. Having the transducer directly applied to the skin can be uncomfortable and unhygienic for the patient. Moreover, the pressure applied to the skin by the contact and movement of the transducer can result in undesirable tissue distortion which can make diagnosis difficult and may even result in misdiagnosis.
- a coupling fluid is usually applied to the patient's skin to occupy any remaining space between the transducer and the patient's skin.
- Ultrasound coupling fluids are important in helping to ensure efficient transmission of ultrasound waves in and out of the body.
- Such coupling fluids are usually viscous, sticky pastes or gels that contain water soluble, non-cross-linked polymers. Traditionally, application and removal of such gels can be messy and unpleasant for the patient.
- the ultrasound coupling materials of the present invention are designed to minimize patient discomfort while making removal and disposal of the ultrasound coupling material easier compared to currently available ultrasound coupling fluid formulations, which are commonly discontiguous gels or pastes that are difficult to remove. For example, many currently available ultrasound coupling fluid formulations must be washed-off or wiped- off in order to be removed. Additionally, the ultrasound coupling materials described herein allow for superior image quality and do not deter from or otherwise interfere with the image quality of the ultrasound images.
- the present invention is directed to ultrasound coupling materials that behave initially like a fluid and ultimately become a semi-solid. While in the initial fluid phase, the ultrasound coupling materials described herein are able to fill any space between a transducer and tissue being imaged. After becoming a semi-solid, the ultrasound coupling materials described herein can be removed as one contiguous mass, allowing for easy removal and disposal of the coupling material. Thus, patient hygiene is improved and patient discomfort is reduced since the ultrasound coupling materials can be removed as one contiguous mass and do not need to be wiped-off or washed-off the patient's skin. Also, issues associated with cleaning and handling ultrasound coupling fluid formulations such as the need for mechanical or other types of seals to prevent leakage are eliminated or at least greatly reduced.
- the ultrasound coupling materials described herein are also designed to be used with an applicator dome or other device which can help eliminate the need for the transducer to be in direct contact with the patient.
- the ultrasound coupling materials are also formulated such that the coupling materials do not deter from or interfere with the image quality of the ultrasound images and the properties of the ultrasound coupling material such as, but not limited to, propagation speed, acoustic impedance and attenuation, are similar to the properties of the tissue being imaged.
- the ultrasound coupling materials of the present invention include a viscosifying agent, a hydrogel or a combination of a viscosifying agent and a hydrogel and a hydrating fluid.
- the ultrasound coupling materials of the present invention are formulated by combining a viscosifying agent, hydrogel or the combination of a hydrogel and a viscosifying agent with a hydrating fluid.
- the ultrasound coupling material Upon introducing the hydrating fluid to the viscosifying agent, hydrogel or the combination of a hydrogel and a viscosifying agent, the ultrasound coupling material is in a fluid phase and is capable of flowing into and filling any space between a transducer and the tissue being imaged. Over time and during the ultrasound procedure, the ultrasound coupling material transforms into a semi-solid.
- the ultrasound coupling material can be removed from the patient and/or the ultrasound machine as one contiguous mass, making removal and disposal of the ultrasound coupling material easier. Also, patient discomfort is minimized since the semi-solid ultrasound coupling material is removed as one contiguous mass and the patient does not need to wipe-off or wash-off a paste or a gel from their skin.
- the ultrasound coupling materials described herein include a viscosifying agent and a hydrating fluid, wherein the hydrating fluid can include, among other materials, at least one multivalent ion.
- the ultrasound coupling materials described herein can include a viscosifying agent such as an ionically charged polymer like sodium alginate, water, a divalent ion such as calcium, an insoluble calcium salt, a calcium sequestrant and a water soluble acid.
- the ultrasound coupling materials described here include a hydrogel and a hydrating fluid.
- the hydrogels used in the ultrasound coupling materials described herein include cross-linked hydrophilic polymers.
- the ultrasound coupling materials of the present invention include cross-linked hydrophilic polymers such as polyacrylic acid, polyacrylamide or co-polymers thereof and a hydrating fluid.
- the ultrasound coupling materials described herein have a solids modulus of between about 10 dynes/cm 2 and about 1000 dynes/cm 2 once they become a semi-solid.
- the ultrasound coupling materials described herein can have a viscosity of between about 100 Pa. to 10,000 Pa.
- the present invention is also directed to methods of making the ultrasound coupling materials of the instant application.
- the methods of making an ultrasound coupling material described herein include the steps of providing a viscosifying agent comprising an ionically charged polymer, introducing a hydrating fluid comprising a soluble multivalent ion to the ionically charge polymer, and forming a semi-solid ultrasound coupling material.
- the methods of making ultrasound coupling materials include the steps of providing a hydrogel, introducing a hydrating fluid comprising water to the hydrogel, and forming a semi-solid ultrasound coupling material.
- the present invention is also directed to systems for ultrasound imaging of soft tissue. Specific systems include, but are not limited to, systems for ultrasound diagnostics.
- the systems described herein include a transducer; an applicator dome having a first side and a second side, wherein the first side is in communication with the transducer and the second side is contoured to accept a breast; a viscosifying agent comprising an ionically charged polymer that is capable of being placed in the second side of the applicator; and a hydrating fluid, wherein upon introducing the hydrating fluid to the ionically charged polymer, a semi-solid ultrasound coupling material is formed.
- kits of the present invention can include a transducer; an applicator dome having a first side and a second side, wherein the first side is in communication with the transducer and the second side is contoured to accept a breast; a hydrogel that is capable of being placed in the second side of the applicator; and a hydrating fluid, wherein upon introducing the hydrating fluid to the hydrophilic cross- linked polymer, a semi-solid ultrasound coupling material is formed.
- kits of the present invention include a hydrogel and a hydrating fluid, wherein the hydrating fluid includes water.
- the kits of the present invention include a viscosifying agent such as an ionically charged polymer; and a hydrating fluid, wherein the hydrating fluid includes a multivalent ion.
- Figure 1 shows a flow chart depicting a method of making the ultrasound coupling materials of the present invention.
- Figure 2 shows an ultrasound system that includes an embodiment of the ultrasound coupling materials described herein.
- Figure 3 shows the creep of a hydrogel sample under 100 g of force.
- Figure 4 shows the creep of hydrogel samples under 100 g of force between
- Figure 5 shows the stress relaxation of hydrogel samples.
- Figure 6 shows the stress relaxation of hydrogel samples.
- Figure 7 shows the stress relaxation of hydrogel samples.
- Figure 8 shows the stress relaxation of an example of a ultrasound coupling material.
- Figure 9 shows the stress relaxation of an example of an ultrasound coupling material.
- fluid phase can refer to the state of the ultrasound coupling material immediately after the hydrating fluid is introduced to the viscosifying agent, hydrogel or the combination of a viscosifying agent and a hydrogel, wherein the ultrasound coupling material behaves more like a fluid than a solid.
- hydrating fluid as used herein can mean a liquid such as a solution or a suspension that when added to a hydrogel, a viscosifying agent or a combination of a hydrogel and a viscosifying agent, a semi-solid ultrasound coupling material is formed.
- hydrogel as used herein can mean a network of natural or synthetic polymers that are highly water absorbent.
- hydrophilic as used herein, describes a polymer or other compound that is capable of absorbing water or swelling in the presence of water, but is not necessarily soluble in water. Hydrophilic polymers contained in the ultrasound coupling materials of the present invention can be partially soluble in water.
- multivalent ion means an element that has the ability to form more than one ion.
- solid can mean a material having qualities of a solid and a liquid and is highly viscous.
- viscosifying agent can mean any agent that is capable of increasing the viscosity of the ultrasound coupling material.
- insoluble salt can mean a salt that does not dissociate at pH 7.
- slow dissolving acid as used herein can mean an acid that does not dissociate immediately upon contact with water.
- the present invention is directed to ultrasound coupling materials that include a viscosifying agent, a hydrogel or a viscosifying agent and a hydrogel and additionally a hydrating fluid.
- the ultrasound coupling materials described herein can be used during an ultrasound procedure as coupling between an ultrasound transducer and the tissue being imaged.
- the ultrasound coupling materials described herein are formulated to behave initially like a fluid during transfer between the transducer and the tissue and, after filling the space between the transducer and the tissue, the material can transform into a semi-solid that can be removed as one contiguous mass following an ultrasound procedure.
- the ultrasound coupling materials described herein are formulated so that the image quality of the ultrasound images is not compromised.
- the ultrasound coupling materials of the present invention are formulated such that the ultrasound properties of the coupling material such as, but not limited to, propagation speed, acoustic impedance and attenuation are close to that of the tissue being imaged.
- the ultrasound coupling materials described herein become a semi-solid the ultrasound coupling materials are stiff enough so that they can be removed from the ultrasound machine and/or the patient in one contiguous mass. However, the ultrasound coupling materials are not so stiff as to deform the tissue being imaged. In some embodiments, the ultrasound coupling materials described herein have a solids modulus of between about 10 dynes/cm 2 and about 1000 dynes/cm 2 once the ultrasound coupling materials become a semi-solid.
- the ultrasound coupling materials described herein can have a viscosity of between 0.1 Pa and 10,000 Pa.
- the ultrasound coupling materials described herein can have an initial viscosity between 0.1 Pa and 100 Pa, between 0.1 Pa and 50 Pa., between 1 Pa. and 20 Pa.
- Initial viscosity is the viscosity of the ultrasound coupling material immediately after the hydrogel, viscosifying agent or the hydrogel and the viscosifying agent and the hydrating fluid are combined and the ultrasound coupling material is a liquid.
- the ultrasound coupling material can have a viscosity of between 100 Pa. and 10,000 Pa., between 500 Pa. and 10,000 Pa., between 750 Pa. and 10,000 Pa., between 1,000 Pa. and 10,000 Pa., between 5,000 Pa. and 10,000 Pa. or between 1,000 Pa. and 5,000 Pa.
- the ultrasound coupling materials described herein have a Gel Integrity Index of about 0.5 kg/mm to about 2500 kg/mm, about 10 kg/mm to about 2500 kg/mm, about 10 kg/mm to about 2000 kg/mm, about 10 kg/mm to about 1000 kg/mm, about 50 kg/mm to about 750 kg/mm, about 50 kg/mm to about 500 kg/mm or about 100 kg/mm to about 500 kg/mm once they become a semisolid.
- the amount of time for the ultrasound coupling material to fill the space between a transducer and the patient and become a semi-solid can vary.
- the ultrasound materials should fill the space between the transducer and the patient and become a semi-sold quickly so that the patient can be imaged as quickly as possible.
- the ultrasound coupling materials should fill the space between the transducer and the patient and become a semi-solid at a rate in which air or other materials that can have a deleterious effect on the image quality are not introduced, or only minimally introduced, into the ultrasound coupling material.
- the ultrasound coupling materials described herein may become a semi-solid after one minute or longer after the hydrogel, viscosifying agent or the hydrogel and the viscosifying agent and the hydrating fluid are combined.
- the ultrasound coupling materials of the present invention become a semi-solid after 1 min., 2 min., 3 min., 4 min., 5 min., 6 min., 7 min., 8 min., 9 min. or 10 min.
- the ultrasound coupling materials of the present invention become a semi-solid between 15 sec. and 3 min., or between 30 sec. and 3 min., or between 30 sec. and 2 min., or between about 30 sec. and 1 min.
- the total deformation of the ultrasound coupling materials of the present invention can be between 0 mm and 10 mm. As a semi-solid, the total deformation of the ultrasound coupling materials can be between 3 mm and 7 mm.
- the hydrogel coupling materials of the present invention include a viscosifying agent and a hydrating liquid.
- the ultrasound coupling materials of the present invention can include an ionically charged polymer, such as a viscosifying agent and an aqueous solution that includes a multivalent ion, an insoluble salt, an acid and a sequestrant, as a hydrating fluid.
- sodium alginate can be used as a viscosifying agent which then can be mixed with a hydrating fluid that includes calcium ions, a calcium salt such as calcium hydrogen phosphate, a calcium sequestrant such as sodium pyrophosphate and an acid such as citric acid.
- the sodium salts of alginic acid are cross-linked by the addition of divalent ions, such as calcium.
- divalent ions such as calcium.
- the addition of calcium salts, an acid and a calcium sequestrant increase the homogeneity of the semi-solid ultrasound coupling material.
- the ultrasound coupling materials of the present invention can include a hydrogel and a hydrating liquid.
- the hydrogel is a cross-linked hydrophilic polymer and the hydrating fluid is an aqueous solution that can include an acid or a base.
- the cross-linked hydrophilic polymer is a co-polymer of polyacrylic acid and polyacrylamide and the hydrating fluid is water.
- the co-polymer of polyacrylic acid and polyacrylamide is treated with or includes a mild acid or surfactant before being hydrated with the hydrating fluid.
- the ultrasound coupling materials described herein include a hydrogel, a viscosifying agent and a hydrating fluid.
- an ultrasound coupling material of the present invention can include a cross-linked hydrophilic polymer such as a polyacrylic acid polyacrylamide co-polymer, sodium alginate as a viscosifying agent and a hydrating fluid which includes water, an acid such as citric acid and, optionally, a preservative.
- the hydrophilic cross-linked polymer can be treated with a surfactant and can be mixed with a salt that can provide a multi-valent ion, such as, but not limited to dicalcium phosphate anhydrous.
- the ultrasound coupling materials described herein can include a viscosifying agent.
- the viscosifying agent can be any agent that increases the viscosity of the ultrasound coupling materials of the present invention.
- the choice of a viscosifying agent depends upon factors such as the desired viscosity and stiffness of the ultrasound coupling materials.
- Suitable viscosifying agents may include, but are not limited to, colloidal agents (e.g., clays, polymers, and guar gum), emulsion forming agents, diatomaceous earth, starches, biopolymers, synthetic polymers, or mixtures thereof.
- Suitable viscosifying agents often are hydratable polymers that have one or more functional groups. These functional groups include, but are not limited to, hydroxyl groups, carboxyl groups, carboxylic acids, derivatives of carboxylic acids, sulfate groups, phosphate groups, propionate groups, and amino groups. In certain embodiments of the present invention, viscosifying agents may be used that comprise hydroxyl groups and/or amino groups. In certain embodiments of the present invention, the viscosifying agents may be biopolymers, and derivatives thereof, that have one or more of these functional groups or monosaccharide units. Viscosifying agents can have a charge, such as an ionic charge or they can be neutral. Examples of viscosifying agents with ionic charges include ionically charged polymers.
- Suitable viscosifying agents include, but are not limited to, sugars, such as sucrose, glucose, maltose, dextrose and fructose, hydric alcohols, such as sorbitol, mannitol, xylitol and maltitol, galactose, mannose, glucoside, xylose, arabinose, glucuronic acid, or pyranosyl sulfate; polymers such as polydextrose, xanthan gum, welan gums, guar gum, hydroxypropyl guar, carboxymethyl hydroxypropyl guar, sodium alginate, carrageenan; cellulose derivatives such as hydroxypropyl cellulose (HPC), hydroxypropyl methylcellulose (HPMC), methylcellulose, polyvinylpyrrolidone (PVP), maltodextrin, carbomer, polyvinyl alcohol, polyethylene glycol (PEG), polyethylene oxide, carboxymethylcellulose (
- synthetic polymers that contain the above-mentioned functional groups may be used.
- synthetic polymers include, but are not limited to, poly(acrylate), poly(methacrylate), poly(ethylene imine), poly(acrylamide), poly(vinyl alcohol), and poly(vinylpyrrolidone).
- suitable viscosifying agents include chitosans, starches and gelatins.
- Suitable clays include kaolinites, montmorillonite, bentonite, hydrous micas, attapulgite, sepiolite, and the like, as well as synthetic clays, such as laponite.
- Surfactants discussed in Section 5.2.2 can also be used as viscosifying agents.
- more than one viscosifying agent can be co-blended with another viscosifying agent.
- sodium alginate can be co- blended with other materials such as gums, starches and polysaccharides, to alter the properties of the ultrasound coupling materials described herein.
- the concentration of the viscosifying agent can be altered to affect the clarity and the stiffness of the ultrasound coupling material.
- the viscosifying agent is present in the ultrasound coupling materials of the present invention in an amount sufficient to provide a desired degree of stiffness for ease of handling.
- Viscosifying agents can be about 0.1 % to 99% of the total weight of the ultrasound coupling materials.
- the viscosifying agent is between about 0.1% to 50%, between about 0.1% to 25%, between about 0.1% to 20%, between about 0.1% to 10%, between about 0.1% to 5%, between about 0.1% to 2%, between about 0.1% to 0.3%, or between about 0.1% to 0.25% of the total weight of the ultrasound coupling material.
- the hydrogel coupling materials described herein include a hydrogel and a hydrating fluid.
- a hydrogel can be defined as a network of natural or synthetic polymers that are insoluble or only partially insoluble in water and highly water absorbent. Suitable polymers can be at least partially soluble in aqueous solutions, such as water, buffered salt solutions, or aqueous alcohol solutions.
- Suitable hydrogels that can be used in the ultrasound coupling materials described herein are formed when an organic polymer (natural or synthetic) is cross- linked via covalent, ionic, or hydrogen bonds to create a three-dimensional open-lattice structure which entraps water molecules to form a hydrogel.
- hydrogels are synthesized so that they contain a large degree of interconnected pores.
- Suitable highly porous hydrogels can absorb and hold many times their own mass in water or hydrating fluid, in many cases more that one hundred times, and are capable of swelling at extremely fast rates, preferably in a matter of minutes. Additionally, the hydrogels will not significantly alter the geometry of the tissue with which they come in contact while hydrating. However, the swollen hydrogels can remain stiff enough for handling purposes while retaining desirable ultrasonic properties.
- the hydration ratio of the hydrogels suitable for use in the ultrasound coupling materials described herein is between about 50 to 150. In certain embodiments, the hydration ratio is 50, 75, 100, 125, or 150.
- suitable hydrogels that can be used in the ultrasound coupling materials described herein can be characterized as contiguous masses, wherein the polymers of the hydrogel are touching or connected in an unbroken sequence.
- Such hydrogels are distinguished from other hydrogel materials that are free-flowing powders consisting of a collection of discreet particles.
- Examples of materials which can be used to form a hydrogel include, but are not limited to, synthetic and naturally occurring hydrophilic cross-linked polymers, polysaccharides and proteins.
- polysaccharides include celluloses such as methyl cellulose, dextrans, and alginate.
- proteins include gelatin and hyaluronic acid.
- hydrophilic cross-linked polymers include both biodegradable and non-degradable polymers, such as polyvinyl alcohol, polyacrylamide, polyacrylic acid, co-polymers of polyacrylamide and polyacrylic acid, polyphosphazines, polyacrylates, polyethylene oxide, and polyalkylene oxide block copolymers (“PoloxamersTM”) such as PlronicsTM or TetronicsTM (polyethylene oxide- polypropylene glycol block co-polymers).
- biodegradable and non-degradable polymers such as polyvinyl alcohol, polyacrylamide, polyacrylic acid, co-polymers of polyacrylamide and polyacrylic acid, polyphosphazines, polyacrylates, polyethylene oxide, and polyalkylene oxide block copolymers (“PoloxamersTM”) such as PlronicsTM or TetronicsTM (polyethylene oxide- polypropylene glycol block co-polymers).
- Suitable polymers can have charged side groups.
- polymers with acidic side groups are polyphosphazenes, polyacrylic acids, poly(meth)acrylic acids, polyvinyl acetate, and sulfonated polymers, such as sulfonated polystyrene.
- Copolymers having acidic side groups formed by reacting acrylic or methacrylic acid and vinyl ether monomers or polymers can also be used.
- acidic groups are carboxylic acid groups, sulfonic acid groups, halogenated (preferably fluorinated) alcohol groups, phenolic OH groups, and acidic OH groups.
- Examples of basic side groups are amino and imino groups.
- Examples of polymers with basic side groups that can be used are polyvinyl amines, polyvinyl pyridine, polyvinyl imidazole, polyvinylpyrrolidone and some imino substituted polyphosphazenes.
- the ammonium or quaternary salt of polymers can also be used.
- alginate can be ionically cross-linked with divalent cations, in water, at room temperature, to form a hydrogel matrix.
- Preferred hydrogels include porous polymer networks composed of hydrophilic cross-linked polymers such as methyl cellulose, dextrans, agarose, polyvinyl alcohol, hyaluronic acid, polyethylene oxide and polyoxyalkylene polymers ("poloxamers”), polyacrylic acid and polyacrylamide and co-polymers thereof.
- Methods for the synthesis of the polymers described above are known to those skilled in the art.
- Cross-linked hydrogels can be synthesized by reacting monomers with other monomers or polymers in the presence of a crosslinker and/or a catalyst to produce an interpenetrating network. The degree of cross-linking can be varied to alter the physical properties of the resulting hydrogel.
- the ratio of monomers, such as acrylic acid to acrylamide can also be altered to modify the crosslink density and the porosity of the hydrogel.
- Suitable surfactants include ionic and non-ionic surfactants.
- suitable surfactants include, but are not limited to, Triton surfactants, Tween and Span surfactants, PluronicTM surfactants (poly(ethylene oxide)- poly(propylene oxide)-poly(ethylene oxide) tri-block co-polymers), SilwetTM surfactants, sodium dodecyl sulfate, albumin, gelatin, or combinations thereof.
- Surfactants of special interest are PluronicTM F 127 or PF 127.
- non- foaming or anti-foaming surfactants are used due to the fact non-foaming surfactants are less likely to allow air to be incorporated into the ultrasound coupling materials, which would interfere with image quality.
- Suitable non-foaming surfactants include non- foaming nonionic surfactants such as sucrose esters, e.g., sucrose cocoate, sucrose stearate and mixtures thereof. Foaming surfactants can be used to the extent that they do not allow air to be incorporated into the ultrasound coupling materials. Additionally, if a foaming surfactant is used an anti-foaming agent such as, but not limited to, cetyl alcohol can be used.
- the hydrogels may be titrated with fluids of different pH to alter the swelling properties of the hydrogel.
- a cross-linked polyacrylic acid-co- polyacrylamide hydrogel can be treated with a mild acid to partially or fully protonate the acrylic acid residues and reduce the degree to which the hydrogel swells. Suitable acids and bases are discussed in Section 5.2.3 below.
- the hydrogel network may be used to stabilize other species, such as ionic species, that may interact synergistically with fluids and other material imbibed into the hydrogel porous network.
- the hydrogels described herein can include salts such as insoluble calcium salts that can react with viscosifying agents like sodium alginate in the hydrating fluid.
- Wetting agents can also be combined with the hydrogels described herein. Suitable wetting agents are discussed in Sections 5.2.3.
- Hydrogels can be about 0.1 % to 99% of the total weight of the ultrasound coupling materials.
- the hydrogels are between about 0.1% to 50%, between about 0.1% to 25%, between about 0.1% to 20%, between about 0.1% to 10%, between about 0.1% to 5%, between about 0.1% to 2%, between about 0.1% to 0.3%, or between about 0.1% to 0.25% of the total weight of the ultrasound coupling material. In other embodiments, hydrogels can be about 0.1 %, 0.25%, 0.3% or 1.3% of the total weight of the ultrasound coupling materials.
- Hydrating fluids are liquids that once added to the viscosifying agent, hydrogel or the combination of a hydrogel and a viscosifying agent, cause the ultrasound coupling material to become a semi-solid.
- the hydrating fluids include water.
- the hydrating fluid can contain other materials such as multivalent ions, insoluble salts, sequestrant agents, wetting agents, acids, bases or a combination thereof.
- Hydrating fluids to be used with viscosifying agents in the ultrasound coupling materials of the present invention include water and a multivalent ion.
- Multivalent ions are elements that can form more than one ion. Examples of multivalent ions include, but are not limited to, alkaline earth metal ions, Group IHA metal ions, Group IVA metal ions, Al +3 , Sn +4 , Pb +4 , Ti +3 , Cr +3 , Mn +3 , Fe +3 , Ni +2 , Cu +2 , Co +3 , Ir +3 , CO 3 '2 , PO 4 '3 , SO 3 "2 , S "2 , Te- 2 , Se '2 , N “3 , P “3 , O 2 “2 , and mixtures thereof.
- Suitable multivalent anions include elements and multi-atom complexes capable of carrying a (- 2) or higher charge such as multi-atom ions, such as sulfate, hydrogen phosphate, and oxalate.
- Other examples of multivalent ions include titanium(III), chromium(III), manganese(III), iron(III), cobalt(III) iridium(IV), and phosphate, Te “2 , S “ , HaSO 4 “2 , MnO 4 “2 , Ca(OH) 4 "2 , Mg(OH) 4 “2 , Hg(OH) 4 “2 , V 2 O 7 “4 , and Mn(OH) 4 “2 ; halide complexes capable of carrying a (-2) or higher charge, such as Co(X) 4 "2 , Cu(X) 4 "2 , Fe(X) 4 “2 , Th(X) 6 “ 2 , and Ti(X) 6 " , where X is fluoride, chloride, bromide
- Preferred multivalent ions include multivalent cations.
- Suitable multivalent cations include, but are not limited to metals capable of carrying a +2 or higher charge, such as Ba +2 , Ca +2 , Cd +2 , Co +2 , Cu +2 , Fe +2 , Hg +2 , Mg +2 , Mn +2 , Ni +2 , Pb +2 , Zn +2 , Pd +2 , Sn +2 , Sr +2 , V +2 Pb +4 , Pu +4 , Sn +4 , Th +4 , U +4 , and Zr +4 ; divalent and higher metal oxides, such as UO 2 +2 and VO +2 ; divalent and higher metal hydroxides, such as AlOH +2 , TiOH +2 , Ti(OH) 2 +2 , and MnOH +2 ; divalent and higher cationic metal halides, such as AlX +2 , Pb(X) 2
- Hydrating liquids can also include at least one insoluble salt.
- Suitable insoluble salts include, but are not limited to, calcium salts like calcium carbonate, calcium phosphate, dicalcium phosphate anhydrous, calcium sulfate; lithium salts like lithium carbonate, lithium citrate, lithium sulfate; cesium salts like cesium carbonate, cesium chloride, cesium nitrate; barium salts like barium sulfate, barium carbonate; magnesium salts like magnesium carbonate, and magnesium stearate; aluminum salts like aluminum silicate; or combinations thereof.
- Hydrating liquids can also include at least one sequestrant. Suitable sequestrants include, but are not limited to, sodium pyrophosphate, sodium citrate or a multidentate ligand such as, but not limited to, ethylenediamine tetraacetic acid (EDTA). [0073] Hydrating liquids can further include at least one wetting agent or surfactant. Wetting agents and surfactants can be non-foaming or foaming, however, non-foaming wetting agents and surfactants are preferred since they are less likely to allow air to be incorporated into the ultrasound coupling materials. Additionally, wetting agents and surfactants can be ionic or anionic.
- Suitable wetting agents and surfactants for the ultrasound coupling materials include, but are not limited to, those surfactants discussed in Section 5.2.2 and polyoxyethylene derivatives of sorbitan esters, such as, polysorbate 20 and polysorbate 80; lecithin; polyoxyethylene and polyoxypropylene ethers; sodium deoxycholate, sodium diocyl sulphate or a combination thereof.
- Hydrating fluids can also include an acid or a base.
- Suitable bases include, but are not limited to, sodium hydroxide, sodium acetate, ammonium hydroxide, potassium hydroxide, ammonium acetate, potassium acetate, sodium phosphate, potassium phosphate, sodium citrate, sodium formate, sodium sulfate, potassium sulfate, potassium fumerate, and combinations thereof.
- Suitable acids include, but are not limited to, hyaluronic acid, citric acid, formic acid, acetic acid, N-acetylglycine, acetylsalicylic acid, fumaric acid, glycolic acid, iminodiacetic acid, itaconic acid, lactic acid, maleic acid, malic acid, nicotinic acid, 2-pyrrolidone-5-carboylic acid, salicylic acid, succinamic acid, succinic acid, ascorbic acid, aspartic acid, glutamic acid, glutaric acid, malonic acid, pyruvic acid, sulfonyldiacetic acid, benzoic acid, epoxysuccinic acid, adipic acid, thiodiacetic acid and thioglycolic acid.
- Suitable acids can also include slow dissolving acids such as fumaric acid, isooctanoic acid and isomers thereof, and adipic acid.
- the amount of the sequestrant and the acid can be adjusted to control the time it takes the ultrasound coupling material to transform from its initial liquid phase to a semi-solid.
- Hydrating fluids that can be used with hydrogels include water. Additionally, similar to the hydrating fluids that can be used with viscosifying agents, the hydrating fluids that can be used with hydrogels can also include acids, bases, wetting agents, surfactants or a combination thereof. Suitable acids, bases, wetting agents and surfactants are discussed in Section 5.2.3.1.
- hydrating fluids that can be used with hydrogels can include a viscosifying agent.
- Suitable viscosifying agents, such as alginates are discussed in Section 5.2.3.1.
- the ultrasound coupling materials of the present invention can include materials that increase the stiffness of the ultrasound coupling materials and allow the ultrasound coupling materials to have "shape memory" meaning the ultrasound coupling material forms to and retains the shape of tissue being imaged, such as a breast, even after the ultrasound coupling material is no longer in contact with the tissue.
- Polymer latex particles such as monodispersed, surface-modified polystyrene particles can be included in the ultrasound coupling materials of the present invention. Such particles can range in size from about 100 nm to several tens of microns. The polymer latex polymers can form close-packed particle arrays that further serve to stiffen the ultrasound coupling materials and allow them to have shape memory.
- a hydrogel network can be prepared in the presence of monodispersed, surface-modified polystyrene polymers.
- the ultrasound coupling materials described herein can further include at least one preservative.
- Suitable preservatives can include, but are not limited to, sodium azide, sodium benzoate, vitamin E, alpha-tocopherol, ascorbic acid, methyl paraben, propyl paraben or sodium bisulphate.
- the ultrasound coupling material described herein can be scented.
- Scented materials can include essential oils or microencapsulated scented compositions. Scents in the ultrasound coupling materials described herein may be selected for an aromatherapy effect, such as providing a relaxing or invigorating mood. As such, any material that exudes pleasant or otherwise desirable odors can be used as a scent.
- the ultrasound coupling materials can have any of the following scents: root beer, cola, vanilla, chocolate, mint, peanut butter, apple, orange, grapefruit, peach, cinnamon, ocean, cut grass, carrot, butterscotch, strawberry, banana, blueberry, bubblegum, lavender, rose, pepper, clove, coffee, tea, oregano, pumpkin pie, raspberry, vinegar, dill, pineapple, sour apple, almond, licorice, cotton candy, popcorn, cherry, pine, apple pie, candy corn, caramel, cherry pie, gingerbread, licorice, marshmallow, lemon, lime, honey, coconut, grape, pina colada, floral, lilac, baby powder, perfume, suntan oil, jasmine, anise, and eucalyptus.
- the ultrasound coupling materials of the present invention can be clear or colored. When the ultrasound coupling materials are colored they can be translucent, i.e. allow light to transmit through the ultrasound coupling material, or opaque i.e. do not allow light to transmit through the ultrasound coupling material.
- the ultrasound coupling materials described herein can be any color including, but not limited to, red, orange, yellow, green, blue, purple, black, white, brown or any shade variant thereof.
- the ultrasound coupling material can be more that one color.
- the individual components of the ultrasound coupling material can be colored. Each individual component of the ultrasound coupling material can be the same or a different color.
- the viscosifying agent can be yellow and the hydrating fluid can be blue and upon mixing the viscosifying agent and the hydrating fluid the ultrasound coupling material can become green.
- the coloring in the ultrasound coupling material does not leach out, stain or otherwise mark the patient.
- the present invention is also directed to methods of making ultrasound coupling materials.
- the present invention includes methods of making an ultrasound coupling material that includes the following steps: providing a cross-linked hydrophilic polymer; introducing a hydrating fluid comprising water; and forming a semi-solid ultrasound coupling material.
- the present invention includes methods of making an ultrasound coupling material that includes the following steps: providing a viscosifying agent comprising an ionically charged polymer; introducing a hydrating fluid comprising a soluble multivalent ion; and forming a semi-solid ultrasound coupling material.
- FIG 1 is a flow diagram that depicts a method of manufacturing the ultrasound coupling materials of the present invention.
- a hydrogel is formed by mixing monomers, at least one cross-linker, a porogen, a surfactant, water and a viscosifier.
- a porogen is an excipient that introduces pores into the hydrogel.
- Porogens can introduce pores into the hydrogel by chemical decomposition of the porogen or physical removal of the porogen.
- Porogens that are capable of chemical decomposition generally decompose into gas and additional bi- products, such porogens include sodium bicarbonate, carbon and nitrogen.
- Porogens that can be physically removed from the hydrogel include salts and sugars that are insoluble in the hydrogel.
- Hydrogel pores are then filled with a material that occupies the voids in the hydrogel without completely hydrating the hydrogel, such as polyethylene glycol (PEG).
- a material that occupies the voids in the hydrogel such as polyethylene glycol (PEG).
- PEG polyethylene glycol
- the hydrogel is transferred to a 80/20 PEG/water bath to prehydrate and de-aerate. This is essentially a pressing process to occlude entrained air and exchange residual water/ethanol. The water in the bath serves to keep the hydrogel partially hydrated to avoid brittleness.
- a low molecular weight PEG (Mw -400) is preferred since it is a liquid at room temperature and is infinitely soluble in water.
- the hydrogel serves to aid the de-aeration process and acts to facilitate hydration of the hydrogel during an ultrasound procedure.
- the hydrogel can then be dipped in a bath of heated higher molecular weight PEG ( Mw-1000) to overcoat and seal the hydrogel. Dipping the hydrogel into the heated PEG bath further serves to occlude entrained air and, on removal, encapsulates the hydrogel with a waxy overcoat.
- PEG molecular weight polyethylene glycol
- Such a process can yield a thin sheet of hydrogel that contains a small amount of water to give it flexibility and a small amount of a highly soluble infiltrant and a coating that facilitates hydration when the sheet is placed into the hydrating fluid.
- a hydrating fluid is formed by mixing water and at least one viscosifying agent.
- the viscosifying agent is a combination of alginate and saccharides. The mixture is then degassed, sterilized and packaged.
- the present invention is also directed to systems for ultrasound imaging of soft tissue.
- soft tissue include, but are not limited to, internal organs such as, the gallbladder, liver, heart, kidneys, pancreas, bladder, thyroid gland, prostate and uterus.
- An example of soft tissue also includes, but is not limited to, breast tissue.
- the present invention includes a system for ultrasound imaging that includes an ultrasound coupling material described herein and an apparatus for ultrasound imaging.
- the present invention is directed to ultrasound diagnostic systems.
- the ultrasound coupling materials are designed to be used as a part of an ultrasound diagnostic system that include an ultrasound coupling material described herein and an apparatus for ultrasound diagnosis such as the apparatus described in United States patent publication no. 2004/0254464.
- the present invention includes ultrasound diagnostic systems that include a transducer; an applicator, such as a dome, comprising a first side and a second side, wherein the first side is in communication with the transducer and the second side is contoured to accept a breast; a hydrophilic cross-linked polymer that is capable of being placed in the second side of the applicator; and a hydrating fluid, wherein upon introducing the hydrating fluid to the hydrophilic cross-linked polymer, a semi-solid ultrasound coupling material is formed.
- the present invention includes ultrasound diagnostic systems that include a transducer; an applicator, such as a dome, comprising a first side and a second side, wherein the first side is in communication with the transducer and the second side is contoured to accept a breast; a viscosifying agent comprising an ionically charged polymer that is capable of being placed in the second side of the applicator; and a hydrating fluid, wherein upon introducing the hydrating fluid to the hydrophilic cross- linked polymer, a semi-solid ultrasound coupling material is formed.
- the ultrasound coupling materials used in the systems described herein are capable of filling the space between the tissue being imaged which in certain embodiments is a breast, and the applicator. Additionally, the ultrasound coupling materials are capable of filling the space between the tissue being imaged which in certain embodiments is a breast, and the applicator while not causing any tissue distortion.
- Ultrasonic transducers may be designed in various ways, and the present invention is not limited to any particular transducer design but rather may be advantageously applied to adapt many different types of transducers.
- Transducer arrays may be curved, with the front surface typically concave, and the individual piezoelectric elements may be substantially square blocks such as described in U.S. Pat. No. 5,042,492 to Dubut.
- Concave arrays may also be constructed with annular elements, such as that described in U.S. Pat. No. 4,537,074 to Dietz. Combining several linear arrays to produce an electronically scanned ultrasonic "pencil" beam from crossed flat acoustic beams is described in U.S. Pat. No.
- an ultrasound coupling material 16 can be disposed in an applicator device in the form of a dome 11 located between the transducer 12 and the patient 13 (indicated by dashed lines).
- the ultrasound coupling material 16 prevents the applicator dome from coming into direct contact with the patient.
- the applicator dome 11 is designed to receive the breast 15 during examination, and the ultrasound coupling material 16, fills the volume between the dome and the breast.
- the applicator dome 11 may be provided in several different sizes to accommodate a wider range of patient-to- patient variations, thereby allowing for variations in patient anatomy.
- the ultrasound coupling materials are used with applicator dome 11, however, the ultrasound coupling materials described herein can be used with other applicators of different shapes and sizes.
- the ultrasound coupling materials described herein can be used with an applicator bag that can be stored flat and later filled with the ultrasound coupling materials described herein.
- the applicator bag can also be inflated to better conform to the tissue being imaged.
- an opening can be provided in the applicator so that the hydrating fluid can enter the applicator through the opening and hydrate the hydrogel, viscosifying agent or the combination of a hydrogel and a viscosifying agent, once the hydrogel, viscosifying agent or a combination of a hydrogel and a viscosifying agent have been placed in the applicator and the applicator has been fitted to the patient.
- Ultrasound coupling materials described herein can be combined with packaging materials and sold as articles of manufacture and kits.
- the articles of manufacture may be combined with packaging material, such as containers including, but not limited to, packets, bottles, jars and pouches, that contain one or more of the components of the ultrasound coupling materials described herein.
- packaging material such as containers including, but not limited to, packets, bottles, jars and pouches, that contain one or more of the components of the ultrasound coupling materials described herein.
- the viscosifying agent, hydrogel or a combination of a viscosifying agent and a hydrogel can be packaged in one container and the hydrating fluid may be packaged in a second container.
- the hydrogels described herein are evacuated and filled, meaning all or almost all of the air is evacuated from the hydrogel and the voids of the hydrogel are then filled with a non-hydrating material that prevents air from penetrating the hydrogel but, at the same time, does not completely hydrate the hydrogel.
- Suitable materials can include PEG or other water soluble polymers, wetting agents or surfactants. Examples of such processes are discussed in Section 6.0. This step helps prevent air from being incorporated into the ultrasound coupling materials which, as mentioned before, will compromise the image quality of the ultrasound images.
- the evacuated and filled hydrogels are then vacuumed packed into packets or pouches to minimize volume of the article of manufacture and prevent air from being incorporated into the hydrogel.
- Hydrating fluids can be premixed and stored in any suitable container such as a bottle. Alternatively, the hydrating fluids can be packaged in multiple components and be mixed just prior to being combined with the hydrogel. The components of ultrasound coupling materials or ultrasound coupling materials themselves may be provided in a pre-packaged form in quantities sufficient for single or multiple uses.
- Kits can include components to make the ultrasound coupling materials of the present invention.
- kits of the present invention include a hydrophilic cross-linked polymer; and a hydrating fluid, wherein the hydrating fluid includes water.
- the kits of the present invention include a viscosifying agent such as an ionically charged polymer; and a hydrating fluid, wherein the hydrating fluid includes a multivalent ion.
- a label or instructions describing how the composition can be combined and used with ultrasound imaging systems, as well as, with patients may be included in such kits. Such instructions may, in some embodiments, be printed on the packaging materials themselves.
- Samples were made by first combining acrylic acid, acrylamide and bisacrylamide with sodium bicarbonate, N 5 N 5 N', N '-tetramethylene diamine, water and PF 127. The mixture was allowed to react for about 1 minute. The resulting hydrogel was rinsed of residual reactants and reaction bi-products, and dried with ethanol.
- Sample 3 was tested for mechanical strength using the Creep Test.
- the Creep Test shows the ability of the hydrogel to retain absorbed water. The greater the distance the more the hydrogel holds under a given stress.
- Figure 3 shows the results of the Creep Test preformed on Sample 3 after initial hydration i.e. when the water and hydrogel material are first combined (Initial test) and 10 minutes after the water and the hydrogel material were combined (After 10 min. equilibration). As shown in Figure 3, the total deformation (shown as distance in mm) for the initial test was greater than that after the hydrogel and water mixture were allowed to equilibrate for 10 minutes.
- Figure 4 shows the deformation of Samples 1, 3, 5 and 7 between 50 and 60 seconds after initial hydration (initial test) and 10 minutes after the water and the hydrogel material were combined (After 10 min. equilibration).
- Figures 6 and 7 show the results of the Stress-Relaxation Test on all seven samples once the hydrogel and water were initially mixed ( Figure 6) and 10 minutes after the water and the hydrogel material were combined ( Figure 7). Samples 2-6 with a hydration ratio between about 75-150 showed desired stiffness that would allow it to resist stress and damage but at the same time conform to tissue and not cause deformation of the tissue.
- Figure 8 shows the results of the Stress-Relaxation test of all ten samples at maximum force and equilibrium force. As shown in Figure 8, Samples 4, 5 and 7 showed the greatest resistance to stress. Figure 9 show the results of the Stress- Relaxation test of Samples 3 and 7. As compared to Sample 3, Sample 7 shows a greater resistance to stress and is a stiffer ultrasound coupling material.
- the polyacrylic-co-polyacrylamide hydrogels of Formulations 1, 2 and 3 were each hydrated with the Hydrating Fluid 1 and Hydrating Fluid 2 as shown as Table 6.
- the hydrogels were hydrated at room temperature using the hydrating fluids to achieve a hydration ratio of 100. Samples were hydrated in an appropriately sized beaker and allowed to equilibrate for several minutes.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Acoustics & Sound (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Abstract
The present invention is generally directed to ultrasound coupling materials. In particular, the present invention is directed to ultrasound coupling materials that include at least one hydrogel, a viscosifying agent or a combination thereof and a hydrating fluid, wherein once the hydrating fluid is introduced to the hydrogel, viscosifying agent or combination thereof, a semi-solid ultrasound coupling material is formed that does not compromise the image quality of the tissue being imaged or distort the tissue being imaged and minimizes patient discomfort since it can be easily removed and/or disposed of.
Description
ULTRASOUND COUPLING MATERIAL
This application claims priority of U.S. provisional patent application No. 60/948,595, filed July 9, 2007, which is incorporated herein be reference in its entirety.
1.0 FIELD OF THE INVENTION
[0001] The present invention is generally directed to ultrasound coupling materials. In particular, the present invention is directed to ultrasound coupling materials that include at least one hydrogel, a viscosifying agent or a combination thereof and a hydrating fluid, wherein the hydrating fluid is introduced to the hydrogel, viscosifying agent or combination thereof to form a semi-solid ultrasound coupling material that does not compromise the image quality of the tissue being imaged or distort the tissue being imaged and minimizes patient discomfort since it can be easily removed and/or disposed of.
2.0 BACKGROUND
[0002] Ultrasound is a non-invasive means of imaging internal soft tissue and soft tissue structures, such as the gallbladder, liver, heart, kidneys, pancreas, bladder, thyroid gland, prostate, uterus and breast tissue. Ultrasound imaging can help in the diagnosis of a wide range of diseases and conditions. For example ultrasound can help detect breast cancer and measure the flow of blood in arteries to detect blockages. Ultrasound can also be used to monitor the growth and development of embryos in the uterus. [0003] During an ultrasound test, high-frequency sound waves, inaudible to the human ear, are transmitted through body tissues using an instrument called a transducer. The ultrasound waves are used to detect variations in tissue densities. The transducer then transmits the information to a computer that displays the information on a monitor. [0004] Since the ultrasound waves are poorly transmitted through air, the transducer is generally placed in direct contact with the patient's skin. Having the transducer directly applied to the skin can be uncomfortable and unhygienic for the patient. Moreover, the pressure applied to the skin by the contact and movement of the transducer can result in undesirable tissue distortion which can make diagnosis difficult and may even result in misdiagnosis.
[0005] In addition to placing the transducer in direct contact with the patient's skin a coupling fluid is usually applied to the patient's skin to occupy any remaining space
between the transducer and the patient's skin. Ultrasound coupling fluids are important in helping to ensure efficient transmission of ultrasound waves in and out of the body. Such coupling fluids are usually viscous, sticky pastes or gels that contain water soluble, non-cross-linked polymers. Traditionally, application and removal of such gels can be messy and unpleasant for the patient.
[0006] Accordingly, there is a need for ultrasound coupling materials that ensure efficient transmission of ultrasound waves in and out of the body. Ideally such coupling materials are easy to use and minimize patient discomfort. Additionally, there is a need for ultrasound systems that include ultrasound coupling materials and minimize or prevent tissue distortion.
3.0 SUMMARY
[0007] These and other objectives are addressed by the present invention. The ultrasound coupling materials of the present invention are designed to minimize patient discomfort while making removal and disposal of the ultrasound coupling material easier compared to currently available ultrasound coupling fluid formulations, which are commonly discontiguous gels or pastes that are difficult to remove. For example, many currently available ultrasound coupling fluid formulations must be washed-off or wiped- off in order to be removed. Additionally, the ultrasound coupling materials described herein allow for superior image quality and do not deter from or otherwise interfere with the image quality of the ultrasound images.
[0008] The present invention is directed to ultrasound coupling materials that behave initially like a fluid and ultimately become a semi-solid. While in the initial fluid phase, the ultrasound coupling materials described herein are able to fill any space between a transducer and tissue being imaged. After becoming a semi-solid, the ultrasound coupling materials described herein can be removed as one contiguous mass, allowing for easy removal and disposal of the coupling material. Thus, patient hygiene is improved and patient discomfort is reduced since the ultrasound coupling materials can be removed as one contiguous mass and do not need to be wiped-off or washed-off the patient's skin. Also, issues associated with cleaning and handling ultrasound coupling fluid formulations such as the need for mechanical or other types of seals to prevent leakage are eliminated or at least greatly reduced.
[0009] The ultrasound coupling materials described herein are also designed to be used with an applicator dome or other device which can help eliminate the need for the transducer to be in direct contact with the patient. The ultrasound coupling materials are also formulated such that the coupling materials do not deter from or interfere with the image quality of the ultrasound images and the properties of the ultrasound coupling material such as, but not limited to, propagation speed, acoustic impedance and attenuation, are similar to the properties of the tissue being imaged. [0010] The ultrasound coupling materials of the present invention include a viscosifying agent, a hydrogel or a combination of a viscosifying agent and a hydrogel and a hydrating fluid. The ultrasound coupling materials of the present invention are formulated by combining a viscosifying agent, hydrogel or the combination of a hydrogel and a viscosifying agent with a hydrating fluid. Upon introducing the hydrating fluid to the viscosifying agent, hydrogel or the combination of a hydrogel and a viscosifying agent, the ultrasound coupling material is in a fluid phase and is capable of flowing into and filling any space between a transducer and the tissue being imaged. Over time and during the ultrasound procedure, the ultrasound coupling material transforms into a semi-solid. Thus, once the ultrasound procedure is complete, the ultrasound coupling material can be removed from the patient and/or the ultrasound machine as one contiguous mass, making removal and disposal of the ultrasound coupling material easier. Also, patient discomfort is minimized since the semi-solid ultrasound coupling material is removed as one contiguous mass and the patient does not need to wipe-off or wash-off a paste or a gel from their skin.
[0011] In certain embodiments the ultrasound coupling materials described herein include a viscosifying agent and a hydrating fluid, wherein the hydrating fluid can include, among other materials, at least one multivalent ion. For example, the ultrasound coupling materials described herein can include a viscosifying agent such as an ionically charged polymer like sodium alginate, water, a divalent ion such as calcium, an insoluble calcium salt, a calcium sequestrant and a water soluble acid. [0012] In other embodiments the ultrasound coupling materials described here include a hydrogel and a hydrating fluid. In some embodiments the hydrogels used in the ultrasound coupling materials described herein include cross-linked hydrophilic polymers. For example, the ultrasound coupling materials of the present invention include cross-linked hydrophilic polymers such as polyacrylic acid, polyacrylamide or co-polymers thereof and a hydrating fluid.
[0013] In some embodiments, the ultrasound coupling materials described herein have a solids modulus of between about 10 dynes/cm2 and about 1000 dynes/cm2 once they become a semi-solid. Alternatively, once the ultrasound coupling materials have become a semi-solid the ultrasound coupling materials described herein can have a viscosity of between about 100 Pa. to 10,000 Pa.
[0014] The present invention is also directed to methods of making the ultrasound coupling materials of the instant application. In certain embodiments the methods of making an ultrasound coupling material described herein include the steps of providing a viscosifying agent comprising an ionically charged polymer, introducing a hydrating fluid comprising a soluble multivalent ion to the ionically charge polymer, and forming a semi-solid ultrasound coupling material.
[0015] In other embodiments, the methods of making ultrasound coupling materials include the steps of providing a hydrogel, introducing a hydrating fluid comprising water to the hydrogel, and forming a semi-solid ultrasound coupling material. [0016] The present invention is also directed to systems for ultrasound imaging of soft tissue. Specific systems include, but are not limited to, systems for ultrasound diagnostics. In certain embodiments, the systems described herein include a transducer; an applicator dome having a first side and a second side, wherein the first side is in communication with the transducer and the second side is contoured to accept a breast; a viscosifying agent comprising an ionically charged polymer that is capable of being placed in the second side of the applicator; and a hydrating fluid, wherein upon introducing the hydrating fluid to the ionically charged polymer, a semi-solid ultrasound coupling material is formed.
[0017] In other embodiments the systems described herein can include a transducer; an applicator dome having a first side and a second side, wherein the first side is in communication with the transducer and the second side is contoured to accept a breast; a hydrogel that is capable of being placed in the second side of the applicator; and a hydrating fluid, wherein upon introducing the hydrating fluid to the hydrophilic cross- linked polymer, a semi-solid ultrasound coupling material is formed. [0018] Finally, the present invention is directed to kits that include components to make the ultrasound coupling materials of the present invention. For example, kits of the present invention include a hydrogel and a hydrating fluid, wherein the hydrating fluid includes water. Alternatively, the kits of the present invention include a
viscosifying agent such as an ionically charged polymer; and a hydrating fluid, wherein the hydrating fluid includes a multivalent ion.
4.0 BRIEF DESCRIPTION OF THE DRAWINGS
[0019] Figure 1 shows a flow chart depicting a method of making the ultrasound coupling materials of the present invention.
[0020] Figure 2 shows an ultrasound system that includes an embodiment of the ultrasound coupling materials described herein.
[0021] Figure 3 shows the creep of a hydrogel sample under 100 g of force.
[0022] Figure 4 shows the creep of hydrogel samples under 100 g of force between
50 and 60 seconds.
[0023] Figure 5 shows the stress relaxation of hydrogel samples.
[0024] Figure 6 shows the stress relaxation of hydrogel samples.
[0025] Figure 7 shows the stress relaxation of hydrogel samples.
[0026] Figure 8 shows the stress relaxation of an example of a ultrasound coupling material.
[0027] Figure 9 shows the stress relaxation of an example of an ultrasound coupling material.
5.0 DETAILED DESCRIPTION
5.1 DEFINITIONS
[0028] The phrase "fluid phase" as used herein can refer to the state of the ultrasound coupling material immediately after the hydrating fluid is introduced to the viscosifying agent, hydrogel or the combination of a viscosifying agent and a hydrogel, wherein the ultrasound coupling material behaves more like a fluid than a solid. [0029] The phrase "hydrating fluid" as used herein can mean a liquid such as a solution or a suspension that when added to a hydrogel, a viscosifying agent or a combination of a hydrogel and a viscosifying agent, a semi-solid ultrasound coupling material is formed.
[0030] The term "hydrogel" as used herein can mean a network of natural or synthetic polymers that are highly water absorbent.
[0031] The term "hydration ratio" means the wet weight of a hydrated hydrogel less the dry weight divided by the dry weight times 100%.
[0032] The term "hydrophilic" as used herein, describes a polymer or other compound that is capable of absorbing water or swelling in the presence of water, but is not necessarily soluble in water. Hydrophilic polymers contained in the ultrasound coupling materials of the present invention can be partially soluble in water.
[0033] The phrase "multivalent ion" as used herein means an element that has the ability to form more than one ion.
[0034] The word "semi-solid" as used herein can mean a material having qualities of a solid and a liquid and is highly viscous.
[0035] The phrase "viscosifying agent" as used herein can mean any agent that is capable of increasing the viscosity of the ultrasound coupling material.
[0036] The phrase "insoluble salt" as used herein can mean a salt that does not dissociate at pH 7.
[0037] The phrase "slow dissolving acid" as used herein can mean an acid that does not dissociate immediately upon contact with water.
[0038] As used herein, the terms "comprising," "comprises", "comprised of,"
"including," "includes," "included," "involving," "involves," "involved," and "such as" are used in their open, non-limiting sense.
5.2 ULTRASOUND COUPLING MATERIALS
[0039] The present invention is directed to ultrasound coupling materials that include a viscosifying agent, a hydrogel or a viscosifying agent and a hydrogel and additionally a hydrating fluid. The ultrasound coupling materials described herein can be used during an ultrasound procedure as coupling between an ultrasound transducer and the tissue being imaged. The ultrasound coupling materials described herein are formulated to behave initially like a fluid during transfer between the transducer and the tissue and, after filling the space between the transducer and the tissue, the material can transform into a semi-solid that can be removed as one contiguous mass following an ultrasound procedure. By transforming into a semi-solid that can be removed as one contiguous mass, issues associated with fluid handling, like the need for mechanical seals to prevent leaking or spillage are eliminated or at least reduced. Also, patient discomfort is reduced and/or clean-up is made easier, since the ultrasound coupling material can be removed and disposed of easily and the patient does not need to wipe or wash-off an ultrasound coupling paste or gel.
[0040] Additionally, the ultrasound coupling materials described herein are formulated so that the image quality of the ultrasound images is not compromised. The ultrasound coupling materials of the present invention are formulated such that the ultrasound properties of the coupling material such as, but not limited to, propagation speed, acoustic impedance and attenuation are close to that of the tissue being imaged. [0041] Once the ultrasound coupling materials described herein become a semi-solid the ultrasound coupling materials are stiff enough so that they can be removed from the ultrasound machine and/or the patient in one contiguous mass. However, the ultrasound coupling materials are not so stiff as to deform the tissue being imaged. In some embodiments, the ultrasound coupling materials described herein have a solids modulus of between about 10 dynes/cm2 and about 1000 dynes/cm2 once the ultrasound coupling materials become a semi-solid.
[0042] The ultrasound coupling materials described herein can have a viscosity of between 0.1 Pa and 10,000 Pa. In certain embodiments the ultrasound coupling materials described herein can have an initial viscosity between 0.1 Pa and 100 Pa, between 0.1 Pa and 50 Pa., between 1 Pa. and 20 Pa. Initial viscosity is the viscosity of the ultrasound coupling material immediately after the hydrogel, viscosifying agent or the hydrogel and the viscosifying agent and the hydrating fluid are combined and the ultrasound coupling material is a liquid. Once the ultrasound coupling material has become a semi-solid, in certain embodiments the ultrasound coupling material can have a viscosity of between 100 Pa. and 10,000 Pa., between 500 Pa. and 10,000 Pa., between 750 Pa. and 10,000 Pa., between 1,000 Pa. and 10,000 Pa., between 5,000 Pa. and 10,000 Pa. or between 1,000 Pa. and 5,000 Pa.
[0043] Alternatively, in some embodiments the ultrasound coupling materials described herein have a Gel Integrity Index of about 0.5 kg/mm to about 2500 kg/mm, about 10 kg/mm to about 2500 kg/mm, about 10 kg/mm to about 2000 kg/mm, about 10 kg/mm to about 1000 kg/mm, about 50 kg/mm to about 750 kg/mm, about 50 kg/mm to about 500 kg/mm or about 100 kg/mm to about 500 kg/mm once they become a semisolid.
[0044] The amount of time for the ultrasound coupling material to fill the space between a transducer and the patient and become a semi-solid can vary. Ideally, the ultrasound materials should fill the space between the transducer and the patient and become a semi-sold quickly so that the patient can be imaged as quickly as possible. However, the ultrasound coupling materials should fill the space between the transducer
and the patient and become a semi-solid at a rate in which air or other materials that can have a deleterious effect on the image quality are not introduced, or only minimally introduced, into the ultrasound coupling material. The ultrasound coupling materials described herein may become a semi-solid after one minute or longer after the hydrogel, viscosifying agent or the hydrogel and the viscosifying agent and the hydrating fluid are combined. In certain embodiments, the ultrasound coupling materials of the present invention become a semi-solid after 1 min., 2 min., 3 min., 4 min., 5 min., 6 min., 7 min., 8 min., 9 min. or 10 min. In other embodiments, the ultrasound coupling materials of the present invention become a semi-solid between 15 sec. and 3 min., or between 30 sec. and 3 min., or between 30 sec. and 2 min., or between about 30 sec. and 1 min. [0045] In other embodiments, when the ultrasound coupling materials of the present invention are tested using the Creep Test and placed under a 100 g force, the total deformation of the ultrasound coupling materials of the present invention can be between 0 mm and 10 mm. As a semi-solid, the total deformation of the ultrasound coupling materials can be between 3 mm and 7 mm.
[0046] In certain embodiments, the hydrogel coupling materials of the present invention include a viscosifying agent and a hydrating liquid. In certain other embodiments, the ultrasound coupling materials of the present invention can include an ionically charged polymer, such as a viscosifying agent and an aqueous solution that includes a multivalent ion, an insoluble salt, an acid and a sequestrant, as a hydrating fluid. For example, sodium alginate can be used as a viscosifying agent which then can be mixed with a hydrating fluid that includes calcium ions, a calcium salt such as calcium hydrogen phosphate, a calcium sequestrant such as sodium pyrophosphate and an acid such as citric acid. Not wanting to be limited to any one theory, the inventors believe that in such an embodiment, the sodium salts of alginic acid are cross-linked by the addition of divalent ions, such as calcium. Moreover, the addition of calcium salts, an acid and a calcium sequestrant increase the homogeneity of the semi-solid ultrasound coupling material.
[0047] In other embodiments the ultrasound coupling materials of the present invention can include a hydrogel and a hydrating liquid. In such embodiments the hydrogel is a cross-linked hydrophilic polymer and the hydrating fluid is an aqueous solution that can include an acid or a base. For example, in certain embodiments the cross-linked hydrophilic polymer is a co-polymer of polyacrylic acid and polyacrylamide and the hydrating fluid is water. In some embodiments the co-polymer
of polyacrylic acid and polyacrylamide is treated with or includes a mild acid or surfactant before being hydrated with the hydrating fluid.
[0048] In still other embodiments the ultrasound coupling materials described herein include a hydrogel, a viscosifying agent and a hydrating fluid. For example, an ultrasound coupling material of the present invention can include a cross-linked hydrophilic polymer such as a polyacrylic acid polyacrylamide co-polymer, sodium alginate as a viscosifying agent and a hydrating fluid which includes water, an acid such as citric acid and, optionally, a preservative. In some embodiments, the hydrophilic cross-linked polymer can be treated with a surfactant and can be mixed with a salt that can provide a multi-valent ion, such as, but not limited to dicalcium phosphate anhydrous.
5.2.1 VISCOSIFYING AGENT
[0049] The ultrasound coupling materials described herein can include a viscosifying agent. The viscosifying agent can be any agent that increases the viscosity of the ultrasound coupling materials of the present invention. The choice of a viscosifying agent depends upon factors such as the desired viscosity and stiffness of the ultrasound coupling materials. Suitable viscosifying agents may include, but are not limited to, colloidal agents (e.g., clays, polymers, and guar gum), emulsion forming agents, diatomaceous earth, starches, biopolymers, synthetic polymers, or mixtures thereof.
[0050] Suitable viscosifying agents often are hydratable polymers that have one or more functional groups. These functional groups include, but are not limited to, hydroxyl groups, carboxyl groups, carboxylic acids, derivatives of carboxylic acids, sulfate groups, phosphate groups, propionate groups, and amino groups. In certain embodiments of the present invention, viscosifying agents may be used that comprise hydroxyl groups and/or amino groups. In certain embodiments of the present invention, the viscosifying agents may be biopolymers, and derivatives thereof, that have one or more of these functional groups or monosaccharide units. Viscosifying agents can have a charge, such as an ionic charge or they can be neutral. Examples of viscosifying agents with ionic charges include ionically charged polymers.
[0051] Suitable viscosifying agents include, but are not limited to, sugars, such as sucrose, glucose, maltose, dextrose and fructose, hydric alcohols, such as sorbitol, mannitol, xylitol and maltitol, galactose, mannose, glucoside, xylose, arabinose,
glucuronic acid, or pyranosyl sulfate; polymers such as polydextrose, xanthan gum, welan gums, guar gum, hydroxypropyl guar, carboxymethyl hydroxypropyl guar, sodium alginate, carrageenan; cellulose derivatives such as hydroxypropyl cellulose (HPC), hydroxypropyl methylcellulose (HPMC), methylcellulose, polyvinylpyrrolidone (PVP), maltodextrin, carbomer, polyvinyl alcohol, polyethylene glycol (PEG), polyethylene oxide, carboxymethylcellulose (CMC) and hydroxyethyl cellulose (HEC). [0052] Additionally, synthetic polymers that contain the above-mentioned functional groups may be used. Examples of such synthetic polymers include, but are not limited to, poly(acrylate), poly(methacrylate), poly(ethylene imine), poly(acrylamide), poly(vinyl alcohol), and poly(vinylpyrrolidone). Other suitable viscosifying agents include chitosans, starches and gelatins. Suitable clays include kaolinites, montmorillonite, bentonite, hydrous micas, attapulgite, sepiolite, and the like, as well as synthetic clays, such as laponite. Surfactants discussed in Section 5.2.2 can also be used as viscosifying agents.
[0053] Additionally, in some embodiments more than one viscosifying agent can be co-blended with another viscosifying agent. For example, sodium alginate can be co- blended with other materials such as gums, starches and polysaccharides, to alter the properties of the ultrasound coupling materials described herein.
[0054] The concentration of the viscosifying agent can be altered to affect the clarity and the stiffness of the ultrasound coupling material. The viscosifying agent is present in the ultrasound coupling materials of the present invention in an amount sufficient to provide a desired degree of stiffness for ease of handling. Viscosifying agents can be about 0.1 % to 99% of the total weight of the ultrasound coupling materials. In certain embodiments, the viscosifying agent is between about 0.1% to 50%, between about 0.1% to 25%, between about 0.1% to 20%, between about 0.1% to 10%, between about 0.1% to 5%, between about 0.1% to 2%, between about 0.1% to 0.3%, or between about 0.1% to 0.25% of the total weight of the ultrasound coupling material.
5.2.2 HYDROGELS
[0055] In certain embodiments the hydrogel coupling materials described herein include a hydrogel and a hydrating fluid. A hydrogel can be defined as a network of natural or synthetic polymers that are insoluble or only partially insoluble in water and highly water absorbent. Suitable polymers can be at least partially soluble in aqueous solutions, such as water, buffered salt solutions, or aqueous alcohol solutions.
[0056] Suitable hydrogels that can be used in the ultrasound coupling materials described herein are formed when an organic polymer (natural or synthetic) is cross- linked via covalent, ionic, or hydrogen bonds to create a three-dimensional open-lattice structure which entraps water molecules to form a hydrogel. Such hydrogels are synthesized so that they contain a large degree of interconnected pores. [0057] Suitable highly porous hydrogels can absorb and hold many times their own mass in water or hydrating fluid, in many cases more that one hundred times, and are capable of swelling at extremely fast rates, preferably in a matter of minutes. Additionally, the hydrogels will not significantly alter the geometry of the tissue with which they come in contact while hydrating. However, the swollen hydrogels can remain stiff enough for handling purposes while retaining desirable ultrasonic properties. In certain embodiments, the hydration ratio of the hydrogels suitable for use in the ultrasound coupling materials described herein is between about 50 to 150. In certain embodiments, the hydration ratio is 50, 75, 100, 125, or 150.
[0058] In certain embodiments, suitable hydrogels that can be used in the ultrasound coupling materials described herein can be characterized as contiguous masses, wherein the polymers of the hydrogel are touching or connected in an unbroken sequence. Such hydrogels are distinguished from other hydrogel materials that are free-flowing powders consisting of a collection of discreet particles.
[0059] Examples of materials which can be used to form a hydrogel include, but are not limited to, synthetic and naturally occurring hydrophilic cross-linked polymers, polysaccharides and proteins. Examples of polysaccharides include celluloses such as methyl cellulose, dextrans, and alginate. Examples of proteins include gelatin and hyaluronic acid. Examples of hydrophilic cross-linked polymers include both biodegradable and non-degradable polymers, such as polyvinyl alcohol, polyacrylamide, polyacrylic acid, co-polymers of polyacrylamide and polyacrylic acid, polyphosphazines, polyacrylates, polyethylene oxide, and polyalkylene oxide block copolymers ("Poloxamers™") such as Plronics™ or Tetronics™ (polyethylene oxide- polypropylene glycol block co-polymers).
[0060J Suitable polymers can have charged side groups. Examples of polymers with acidic side groups are polyphosphazenes, polyacrylic acids, poly(meth)acrylic acids, polyvinyl acetate, and sulfonated polymers, such as sulfonated polystyrene. Copolymers having acidic side groups formed by reacting acrylic or methacrylic acid and vinyl ether monomers or polymers can also be used. Examples of acidic groups are
carboxylic acid groups, sulfonic acid groups, halogenated (preferably fluorinated) alcohol groups, phenolic OH groups, and acidic OH groups.
[0061] Examples of basic side groups are amino and imino groups. Examples of polymers with basic side groups that can be used are polyvinyl amines, polyvinyl pyridine, polyvinyl imidazole, polyvinylpyrrolidone and some imino substituted polyphosphazenes. The ammonium or quaternary salt of polymers can also be used. Additionally, alginate can be ionically cross-linked with divalent cations, in water, at room temperature, to form a hydrogel matrix.
[0062] Preferred hydrogels include porous polymer networks composed of hydrophilic cross-linked polymers such as methyl cellulose, dextrans, agarose, polyvinyl alcohol, hyaluronic acid, polyethylene oxide and polyoxyalkylene polymers ("poloxamers"), polyacrylic acid and polyacrylamide and co-polymers thereof. [0063] Methods for the synthesis of the polymers described above are known to those skilled in the art. Cross-linked hydrogels can be synthesized by reacting monomers with other monomers or polymers in the presence of a crosslinker and/or a catalyst to produce an interpenetrating network. The degree of cross-linking can be varied to alter the physical properties of the resulting hydrogel. The ratio of monomers, such as acrylic acid to acrylamide, can also be altered to modify the crosslink density and the porosity of the hydrogel.
[0064] Additionally, the hydrogels can be combined with or treated with a surfactant to increase hydration rates. Suitable surfactants include ionic and non-ionic surfactants. For example suitable surfactants include, but are not limited to, Triton surfactants, Tween and Span surfactants, Pluronic™ surfactants (poly(ethylene oxide)- poly(propylene oxide)-poly(ethylene oxide) tri-block co-polymers), Silwet™ surfactants, sodium dodecyl sulfate, albumin, gelatin, or combinations thereof. Surfactants of special interest are Pluronic™ F 127 or PF 127. Preferably, non- foaming or anti-foaming surfactants are used due to the fact non-foaming surfactants are less likely to allow air to be incorporated into the ultrasound coupling materials, which would interfere with image quality. Suitable non-foaming surfactants include non- foaming nonionic surfactants such as sucrose esters, e.g., sucrose cocoate, sucrose stearate and mixtures thereof. Foaming surfactants can be used to the extent that they do not allow air to be incorporated into the ultrasound coupling materials. Additionally, if a foaming surfactant is used an anti-foaming agent such as, but not limited to, cetyl alcohol can be used.
[0065] The hydrogels may be titrated with fluids of different pH to alter the swelling properties of the hydrogel. For example, a cross-linked polyacrylic acid-co- polyacrylamide hydrogel can be treated with a mild acid to partially or fully protonate the acrylic acid residues and reduce the degree to which the hydrogel swells. Suitable acids and bases are discussed in Section 5.2.3 below.
[0066] Also, the hydrogel network may be used to stabilize other species, such as ionic species, that may interact synergistically with fluids and other material imbibed into the hydrogel porous network. For example, the hydrogels described herein can include salts such as insoluble calcium salts that can react with viscosifying agents like sodium alginate in the hydrating fluid. Wetting agents can also be combined with the hydrogels described herein. Suitable wetting agents are discussed in Sections 5.2.3. [0067] Hydrogels can be about 0.1 % to 99% of the total weight of the ultrasound coupling materials. In certain embodiments, the hydrogels are between about 0.1% to 50%, between about 0.1% to 25%, between about 0.1% to 20%, between about 0.1% to 10%, between about 0.1% to 5%, between about 0.1% to 2%, between about 0.1% to 0.3%, or between about 0.1% to 0.25% of the total weight of the ultrasound coupling material. In other embodiments, hydrogels can be about 0.1 %, 0.25%, 0.3% or 1.3% of the total weight of the ultrasound coupling materials.
5.2.3 HYDRATING FLUIDS
[0068] Hydrating fluids are liquids that once added to the viscosifying agent, hydrogel or the combination of a hydrogel and a viscosifying agent, cause the ultrasound coupling material to become a semi-solid. In most instances the hydrating fluids include water. Depending on the viscosifying agent or hydrogel being hydrated as well as the desired characteristics of the ultrasound coupling material, the hydrating fluid can contain other materials such as multivalent ions, insoluble salts, sequestrant agents, wetting agents, acids, bases or a combination thereof.
5.2.3.1 Hydrating Fluids to be Used with Viscosifying Agents
[0069] Hydrating fluids to be used with viscosifying agents in the ultrasound coupling materials of the present invention include water and a multivalent ion. Multivalent ions are elements that can form more than one ion. Examples of multivalent ions include, but are not limited to, alkaline earth metal ions, Group IHA metal ions, Group IVA metal ions, Al+3, Sn+4, Pb+4, Ti+3, Cr+3, Mn+3, Fe+3, Ni+2, Cu+2, Co+3, Ir+3, CO3 '2, PO4 '3, SO3 "2, S"2, Te-2, Se'2, N"3, P"3, O2 "2, and mixtures thereof. Suitable
multivalent anions include elements and multi-atom complexes capable of carrying a (- 2) or higher charge such as multi-atom ions, such as sulfate, hydrogen phosphate, and oxalate. Other examples of multivalent ions include titanium(III), chromium(III), manganese(III), iron(III), cobalt(III) iridium(IV), and phosphate, Te"2, S", HaSO4 "2, MnO4 "2, Ca(OH)4 "2, Mg(OH)4 "2, Hg(OH)4 "2, V2O7 "4, and Mn(OH)4 "2; halide complexes capable of carrying a (-2) or higher charge, such as Co(X)4 "2, Cu(X)4 "2, Fe(X)4 "2, Th(X)6 " 2, and Ti(X)6 " , where X is fluoride, chloride, bromide, or iodide; and mixtures thereof. [0070] Preferred multivalent ions include multivalent cations. Suitable multivalent cations include, but are not limited to metals capable of carrying a +2 or higher charge, such as Ba+2, Ca+2, Cd+2, Co+2, Cu+2, Fe+2, Hg+2, Mg+2, Mn+2, Ni+2, Pb+2, Zn+2, Pd+2, Sn+2, Sr+2, V+2Pb+4, Pu+4, Sn+4, Th+4, U+4, and Zr+4; divalent and higher metal oxides, such as UO2 +2 and VO+2; divalent and higher metal hydroxides, such as AlOH+2, TiOH+2, Ti(OH)2 +2, and MnOH+2; divalent and higher cationic metal halides, such as AlX+2, Pb(X)2 +2, Ti(X)2 +2, and MnX+2, where X is fluoride, chloride, bromide, or iodide; and mixtures thereof.
[0071] Hydrating liquids can also include at least one insoluble salt. Suitable insoluble salts include, but are not limited to, calcium salts like calcium carbonate, calcium phosphate, dicalcium phosphate anhydrous, calcium sulfate; lithium salts like lithium carbonate, lithium citrate, lithium sulfate; cesium salts like cesium carbonate, cesium chloride, cesium nitrate; barium salts like barium sulfate, barium carbonate; magnesium salts like magnesium carbonate, and magnesium stearate; aluminum salts like aluminum silicate; or combinations thereof.
[0072] Hydrating liquids can also include at least one sequestrant. Suitable sequestrants include, but are not limited to, sodium pyrophosphate, sodium citrate or a multidentate ligand such as, but not limited to, ethylenediamine tetraacetic acid (EDTA). [0073] Hydrating liquids can further include at least one wetting agent or surfactant. Wetting agents and surfactants can be non-foaming or foaming, however, non-foaming wetting agents and surfactants are preferred since they are less likely to allow air to be incorporated into the ultrasound coupling materials. Additionally, wetting agents and surfactants can be ionic or anionic. Suitable wetting agents and surfactants for the ultrasound coupling materials include, but are not limited to, those surfactants discussed in Section 5.2.2 and polyoxyethylene derivatives of sorbitan esters, such as, polysorbate 20 and polysorbate 80; lecithin; polyoxyethylene and polyoxypropylene ethers; sodium deoxycholate, sodium diocyl sulphate or a combination thereof.
[0074] Hydrating fluids can also include an acid or a base. Suitable bases include, but are not limited to, sodium hydroxide, sodium acetate, ammonium hydroxide, potassium hydroxide, ammonium acetate, potassium acetate, sodium phosphate, potassium phosphate, sodium citrate, sodium formate, sodium sulfate, potassium sulfate, potassium fumerate, and combinations thereof. Suitable acids include, but are not limited to, hyaluronic acid, citric acid, formic acid, acetic acid, N-acetylglycine, acetylsalicylic acid, fumaric acid, glycolic acid, iminodiacetic acid, itaconic acid, lactic acid, maleic acid, malic acid, nicotinic acid, 2-pyrrolidone-5-carboylic acid, salicylic acid, succinamic acid, succinic acid, ascorbic acid, aspartic acid, glutamic acid, glutaric acid, malonic acid, pyruvic acid, sulfonyldiacetic acid, benzoic acid, epoxysuccinic acid, adipic acid, thiodiacetic acid and thioglycolic acid. Suitable acids can also include slow dissolving acids such as fumaric acid, isooctanoic acid and isomers thereof, and adipic acid. The amount of the sequestrant and the acid can be adjusted to control the time it takes the ultrasound coupling material to transform from its initial liquid phase to a semi-solid.
5.2.3.2 Hydrating Fluids that can be Used with Hydrogels
[0075] Hydrating fluids that can be used with hydrogels include water. Additionally, similar to the hydrating fluids that can be used with viscosifying agents, the hydrating fluids that can be used with hydrogels can also include acids, bases, wetting agents, surfactants or a combination thereof. Suitable acids, bases, wetting agents and surfactants are discussed in Section 5.2.3.1.
[0076] Also, hydrating fluids that can be used with hydrogels can include a viscosifying agent. Suitable viscosifying agents, such as alginates are discussed in Section 5.2.3.1.
5.2.4 ADDITIONAL MATERIALS
5.2.4.1 Shape Memory Materials
[0077] Additionally, the ultrasound coupling materials of the present invention can include materials that increase the stiffness of the ultrasound coupling materials and allow the ultrasound coupling materials to have "shape memory" meaning the ultrasound coupling material forms to and retains the shape of tissue being imaged, such as a breast, even after the ultrasound coupling material is no longer in contact with the tissue. [0078] Polymer latex particles such as monodispersed, surface-modified polystyrene particles can be included in the ultrasound coupling materials of the present invention.
Such particles can range in size from about 100 nm to several tens of microns. The polymer latex polymers can form close-packed particle arrays that further serve to stiffen the ultrasound coupling materials and allow them to have shape memory. In certain embodiments, a hydrogel network can be prepared in the presence of monodispersed, surface-modified polystyrene polymers.
5.2.4.2 Preservatives
[0079] The ultrasound coupling materials described herein can further include at least one preservative. Suitable preservatives can include, but are not limited to, sodium azide, sodium benzoate, vitamin E, alpha-tocopherol, ascorbic acid, methyl paraben, propyl paraben or sodium bisulphate.
5.2.4.3 Scents
[0080] In certain embodiments of the present invention, the ultrasound coupling material described herein can be scented. Scented materials can include essential oils or microencapsulated scented compositions. Scents in the ultrasound coupling materials described herein may be selected for an aromatherapy effect, such as providing a relaxing or invigorating mood. As such, any material that exudes pleasant or otherwise desirable odors can be used as a scent.
[0081] The ultrasound coupling materials can have any of the following scents: root beer, cola, vanilla, chocolate, mint, peanut butter, apple, orange, grapefruit, peach, cinnamon, ocean, cut grass, carrot, butterscotch, strawberry, banana, blueberry, bubblegum, lavender, rose, pepper, clove, coffee, tea, oregano, pumpkin pie, raspberry, vinegar, dill, pineapple, sour apple, almond, licorice, cotton candy, popcorn, cherry, pine, apple pie, candy corn, caramel, cherry pie, gingerbread, licorice, marshmallow, lemon, lime, honey, coconut, grape, pina colada, floral, lilac, baby powder, perfume, suntan oil, jasmine, anise, and eucalyptus.
5.2.4.4 Colors
[0082] Additionally, the ultrasound coupling materials of the present invention can be clear or colored. When the ultrasound coupling materials are colored they can be translucent, i.e. allow light to transmit through the ultrasound coupling material, or opaque i.e. do not allow light to transmit through the ultrasound coupling material. The ultrasound coupling materials described herein can be any color including, but not limited to, red, orange, yellow, green, blue, purple, black, white, brown or any shade variant thereof.
[0083] In certain embodiments, the ultrasound coupling material can be more that one color. Also, in certain embodiments the individual components of the ultrasound coupling material can be colored. Each individual component of the ultrasound coupling material can be the same or a different color. For example, the viscosifying agent can be yellow and the hydrating fluid can be blue and upon mixing the viscosifying agent and the hydrating fluid the ultrasound coupling material can become green. [0084] Preferably, the coloring in the ultrasound coupling material does not leach out, stain or otherwise mark the patient.
6.0 METHODS OF MAKING
[0085] The present invention is also directed to methods of making ultrasound coupling materials. In certain embodiments, the present invention includes methods of making an ultrasound coupling material that includes the following steps: providing a cross-linked hydrophilic polymer; introducing a hydrating fluid comprising water; and forming a semi-solid ultrasound coupling material.
[0086] In other embodiments the present invention includes methods of making an ultrasound coupling material that includes the following steps: providing a viscosifying agent comprising an ionically charged polymer; introducing a hydrating fluid comprising a soluble multivalent ion; and forming a semi-solid ultrasound coupling material.
[0087] Figure 1, is a flow diagram that depicts a method of manufacturing the ultrasound coupling materials of the present invention. As shown in Figure 1, a hydrogel is formed by mixing monomers, at least one cross-linker, a porogen, a surfactant, water and a viscosifier. A porogen is an excipient that introduces pores into the hydrogel. Porogens can introduce pores into the hydrogel by chemical decomposition of the porogen or physical removal of the porogen. Porogens that are capable of chemical decomposition generally decompose into gas and additional bi- products, such porogens include sodium bicarbonate, carbon and nitrogen. Porogens that can be physically removed from the hydrogel include salts and sugars that are insoluble in the hydrogel.
[0088] As shown in Figure 1, monomers such as acrylic acid (AA) and acrylamide (Am) are combined with a cross-linker such as bisacrylamide, a porogen such as sodium bicarbonate, water and a surfactant and/or viscosifying agent such as Pluronic™ F 127. The mixture is heated until the desired hydrogel is formed. To clean and de-areate the
hydrogel, the hydrogel is first washed with a water-ethanol mixture. The ratio between water and ethanol can be between 70/30 ethanol/water to 95/5 ethanol water. The water/ethanol wash removes residual reactants and reaction bi-products which could cause oxidation and yellowing of the hydrogel. Residual bicarbonate can also cause bubble inclusion if the hydrating fluid is acidic. Such bubbles could be detrimental to ultrasound image quality.
[0089] Hydrogel pores are then filled with a material that occupies the voids in the hydrogel without completely hydrating the hydrogel, such as polyethylene glycol (PEG). For example, once the hydrogel is washed and sterilized, the hydrogel is transferred to a 80/20 PEG/water bath to prehydrate and de-aerate. This is essentially a pressing process to occlude entrained air and exchange residual water/ethanol. The water in the bath serves to keep the hydrogel partially hydrated to avoid brittleness. A low molecular weight PEG (Mw -400) is preferred since it is a liquid at room temperature and is infinitely soluble in water. Therefore, it serves to aid the de-aeration process and acts to facilitate hydration of the hydrogel during an ultrasound procedure. [0090] To further stabilize the hydrogel, the hydrogel can then be dipped in a bath of heated higher molecular weight PEG ( Mw-1000) to overcoat and seal the hydrogel. Dipping the hydrogel into the heated PEG bath further serves to occlude entrained air and, on removal, encapsulates the hydrogel with a waxy overcoat. Such a process can yield a thin sheet of hydrogel that contains a small amount of water to give it flexibility and a small amount of a highly soluble infiltrant and a coating that facilitates hydration when the sheet is placed into the hydrating fluid. Such a process allows the hydrogel to be placed into 400C water using 2.5g hydrogel / 10OmL of water and be fully hydrated and bubble-free in 2-3 minutes. The filled and pressed hydrogel is then packaged. [0091] Also, as shown in Figure 1, a hydrating fluid is formed by mixing water and at least one viscosifying agent. In the embodiment shown in Figure 1, the viscosifying agent is a combination of alginate and saccharides. The mixture is then degassed, sterilized and packaged.
7.0 ULTRASOUND SYSTEMS
[00921 The present invention is also directed to systems for ultrasound imaging of soft tissue. Examples of soft tissue include, but are not limited to, internal organs such as, the gallbladder, liver, heart, kidneys, pancreas, bladder, thyroid gland, prostate and uterus. An example of soft tissue also includes, but is not limited to, breast tissue. In
certain embodiments the present invention includes a system for ultrasound imaging that includes an ultrasound coupling material described herein and an apparatus for ultrasound imaging.
[0093] In certain embodiments the present invention is directed to ultrasound diagnostic systems. The ultrasound coupling materials are designed to be used as a part of an ultrasound diagnostic system that include an ultrasound coupling material described herein and an apparatus for ultrasound diagnosis such as the apparatus described in United States patent publication no. 2004/0254464.
[0094] In certain embodiments, the present invention includes ultrasound diagnostic systems that include a transducer; an applicator, such as a dome, comprising a first side and a second side, wherein the first side is in communication with the transducer and the second side is contoured to accept a breast; a hydrophilic cross-linked polymer that is capable of being placed in the second side of the applicator; and a hydrating fluid, wherein upon introducing the hydrating fluid to the hydrophilic cross-linked polymer, a semi-solid ultrasound coupling material is formed.
[0095] In other embodiments the present invention includes ultrasound diagnostic systems that include a transducer; an applicator, such as a dome, comprising a first side and a second side, wherein the first side is in communication with the transducer and the second side is contoured to accept a breast; a viscosifying agent comprising an ionically charged polymer that is capable of being placed in the second side of the applicator; and a hydrating fluid, wherein upon introducing the hydrating fluid to the hydrophilic cross- linked polymer, a semi-solid ultrasound coupling material is formed. The ultrasound coupling materials used in the systems described herein are capable of filling the space between the tissue being imaged which in certain embodiments is a breast, and the applicator. Additionally, the ultrasound coupling materials are capable of filling the space between the tissue being imaged which in certain embodiments is a breast, and the applicator while not causing any tissue distortion.
[0096] Ultrasonic transducers may be designed in various ways, and the present invention is not limited to any particular transducer design but rather may be advantageously applied to adapt many different types of transducers. Transducer arrays may be curved, with the front surface typically concave, and the individual piezoelectric elements may be substantially square blocks such as described in U.S. Pat. No. 5,042,492 to Dubut. Concave arrays may also be constructed with annular elements, such as that described in U.S. Pat. No. 4,537,074 to Dietz. Combining several linear
arrays to produce an electronically scanned ultrasonic "pencil" beam from crossed flat acoustic beams is described in U.S. Pat. No. 5,797,845 to Barabash et al. More recently, a new type of acoustic transducer has been developed in which silicon micromachining techniques are used to fabricate suspended membranes that are excited capacitively, as described in detail by Ladabaum et al., Surface Micromachined Capacitive Ultrasonic Transducers, IEEE Trans, on Ultrasonics, Ferroelectrics, and Freq. Control, Vol. 45, No. 3, May 1998.
[0097] To achieve good acoustic coupling between the transducer and the object under examination, the ultrasound coupling materials described herein can be placed between the transducer and the patient to eliminate any air space and replace it with an interface whose acoustic impedance is better matched to the tissue being imaged. As shown in Figure 2, an ultrasound coupling material 16 can be disposed in an applicator device in the form of a dome 11 located between the transducer 12 and the patient 13 (indicated by dashed lines). The ultrasound coupling material 16 prevents the applicator dome from coming into direct contact with the patient. The applicator dome 11 is designed to receive the breast 15 during examination, and the ultrasound coupling material 16, fills the volume between the dome and the breast. The applicator dome 11 may be provided in several different sizes to accommodate a wider range of patient-to- patient variations, thereby allowing for variations in patient anatomy. [0098] As shown in Figure 2, the ultrasound coupling materials are used with applicator dome 11, however, the ultrasound coupling materials described herein can be used with other applicators of different shapes and sizes. For example, the ultrasound coupling materials described herein can be used with an applicator bag that can be stored flat and later filled with the ultrasound coupling materials described herein. In another embodiment, the applicator bag can also be inflated to better conform to the tissue being imaged.
[0099] Optionally, an opening can be provided in the applicator so that the hydrating fluid can enter the applicator through the opening and hydrate the hydrogel, viscosifying agent or the combination of a hydrogel and a viscosifying agent, once the hydrogel, viscosifying agent or a combination of a hydrogel and a viscosifying agent have been placed in the applicator and the applicator has been fitted to the patient.
8.0 ARTICLES OF MANUFACTURE AND KITS
[00100] Ultrasound coupling materials described herein can be combined with packaging materials and sold as articles of manufacture and kits. The articles of manufacture may be combined with packaging material, such as containers including, but not limited to, packets, bottles, jars and pouches, that contain one or more of the components of the ultrasound coupling materials described herein. For example, the viscosifying agent, hydrogel or a combination of a viscosifying agent and a hydrogel can be packaged in one container and the hydrating fluid may be packaged in a second container.
[0100] In certain embodiments, prior to packaging, the hydrogels described herein are evacuated and filled, meaning all or almost all of the air is evacuated from the hydrogel and the voids of the hydrogel are then filled with a non-hydrating material that prevents air from penetrating the hydrogel but, at the same time, does not completely hydrate the hydrogel. Suitable materials can include PEG or other water soluble polymers, wetting agents or surfactants. Examples of such processes are discussed in Section 6.0. This step helps prevent air from being incorporated into the ultrasound coupling materials which, as mentioned before, will compromise the image quality of the ultrasound images.
[0101] In certain embodiments, the evacuated and filled hydrogels are then vacuumed packed into packets or pouches to minimize volume of the article of manufacture and prevent air from being incorporated into the hydrogel. [0102] Hydrating fluids can be premixed and stored in any suitable container such as a bottle. Alternatively, the hydrating fluids can be packaged in multiple components and be mixed just prior to being combined with the hydrogel. The components of ultrasound coupling materials or ultrasound coupling materials themselves may be provided in a pre-packaged form in quantities sufficient for single or multiple uses. [0103] Kits can include components to make the ultrasound coupling materials of the present invention. For example kits of the present invention include a hydrophilic cross-linked polymer; and a hydrating fluid, wherein the hydrating fluid includes water. Alternatively, the kits of the present invention include a viscosifying agent such as an ionically charged polymer; and a hydrating fluid, wherein the hydrating fluid includes a multivalent ion. A label or instructions describing how the composition can be combined and used with ultrasound imaging systems, as well as, with patients may be
included in such kits. Such instructions may, in some embodiments, be printed on the packaging materials themselves.
9.0 EXAMPLES
9.1 Example 1
[0104] The effect of hydration on hydrogels was tested on polyacrylic-co- polyacrylamide hydrogels. The polyacrylic-co-polyacrylamide hydrogels were synthesized according to the formulation in Table 1. Table 1
[0105] Samples were made by first combining acrylic acid, acrylamide and bisacrylamide with sodium bicarbonate, N5N5N', N '-tetramethylene diamine, water and PF 127. The mixture was allowed to react for about 1 minute. The resulting hydrogel was rinsed of residual reactants and reaction bi-products, and dried with ethanol.
[0106] Seven hydrogel samples were hydrated with various amounts of water. Table 2 shows the hydration ratios of the seven samples. Table 2
9.1.1 Creep Test
[0107] Sample 3 was tested for mechanical strength using the Creep Test. The Creep Test shows the ability of the hydrogel to retain absorbed water. The greater the distance the more the hydrogel holds under a given stress. Figure 3 shows the results of the Creep Test preformed on Sample 3 after initial hydration i.e. when the water and hydrogel material are first combined (Initial test) and 10 minutes after the water and the hydrogel material were combined (After 10 min. equilibration). As shown in Figure 3, the total deformation (shown as distance in mm) for the initial test was greater than that after the hydrogel and water mixture were allowed to equilibrate for 10 minutes. Figure 4 shows the deformation of Samples 1, 3, 5 and 7 between 50 and 60 seconds after initial hydration (initial test) and 10 minutes after the water and the hydrogel material were combined (After 10 min. equilibration).
9.1.2 Stress-Relaxation Test
[0108] The seven samples were also tested using the Stress-Relaxation Test. This test shows the ability of the hydrogel to resist applied stress. The higher the value, the stiffer and stronger the hydrogel is and the hydrogel's ability to resist damage during manufacturing and handling is improved. Figure 5 shows the results of the Stress- Relaxation Test preformed on Sample 2 both once the water and hydrogel were initially mixed (Initial test, Sample 2) and 10 minutes after the water and the hydrogel material were combined (After 10 min., Sample 2) and on Sample 6 once the water and hydrogel
were initially mixed (Initial test, Sample 6). As shown in Figure 5, Sample 2, 10 minutes after the water and the hydrogel material were combined, required the most force before breaking and was the stiffest out of the three samples tested. Figures 6 and 7 show the results of the Stress-Relaxation Test on all seven samples once the hydrogel and water were initially mixed (Figure 6) and 10 minutes after the water and the hydrogel material were combined (Figure 7). Samples 2-6 with a hydration ratio between about 75-150 showed desired stiffness that would allow it to resist stress and damage but at the same time conform to tissue and not cause deformation of the tissue.
9.2 Example 2
[0109] Ten ultrasound coupling material samples comprising different hydrating fluids were synthesized and tested using the Stress-Relaxation Test. Polyacrylic-co- polyacrylamide hydrogels were synthesized according to the formulation in Table 1. Hydrogels were synthesized by first combining acrylic acid, acrylamide and the bisacrylamide with the sodium bicarbonate, N,N,N',N'-tetramethylene diamine, water, and PF 127. The mixture was allowed to react for about 1 minute. The resulting hydrogel was rinsed of residual reactants and reaction bi-products, and dried with ethanol.
[0110] Hydrating fluids were formulated as shown in Table 3. Table 3
[0111] Either 0.3 g or 1.3 g of the polyacrylic-co-polyacrylamide hydrogel was hydrated with the hydrating fluids shown in Table 3. The hydrogels were hydrated at room temperature using the hydrating fluids to achieve a hydration ratio of 100.
Samples were hydrated in an appropriately sized beaker and allowed to equilibrate for several minutes.
9.2.1 Stress-Relaxation Test
[0112] Figure 8 shows the results of the Stress-Relaxation test of all ten samples at maximum force and equilibrium force. As shown in Figure 8, Samples 4, 5 and 7 showed the greatest resistance to stress. Figure 9 show the results of the Stress- Relaxation test of Samples 3 and 7. As compared to Sample 3, Sample 7 shows a greater resistance to stress and is a stiffer ultrasound coupling material.
9.3 Example 3
[0113] Hydrogels were synthesized according to the formulation in Table 4. Table 4
[0114] To make the hydrogel of Formulation 1, sodium bicarbonate and water were mixed and added to a heat reaction flask. Acrylamide, acrylic acid, bisacrylamide, PFl 27, N,N,N',N'-tetramethylene diamine and ammonium persulfate were mixed in a separate container and then added to the heat reaction flask containing the sodium bicarbonate solution to produce a hydrogel.
[0115] To make the hydrogel of Formulations 2 and 3, sodium bicarbonate, dicalcium phosphate anhydrous and water were mixed and added to a heat reaction
flask. Acrylamide, acrylic acid, bisacrylamide, PF 127, N,N,N',N'-tetramethylene diamine and ammonium persulfate were mixed in a separate container and then added to the heat reaction flask containing the sodium bicarbonate solution to produce a hydrogel. [0116] Hydrating fluids were synthesized according to the formulation in Table 5. Table 5
[0117] The polyacrylic-co-polyacrylamide hydrogels of Formulations 1, 2 and 3 were each hydrated with the Hydrating Fluid 1 and Hydrating Fluid 2 as shown as Table 6. The hydrogels were hydrated at room temperature using the hydrating fluids to achieve a hydration ratio of 100. Samples were hydrated in an appropriately sized beaker and allowed to equilibrate for several minutes.
[0118] The description and examples contained herein is for purposes of illustration and not for purposes of limitation. Changes and modifications may be made to the embodiments of the description and still be within the scope of the invention. Furthermore, obvious changes, modifications or variations will occur to those skilled in the art. Also, all references cited above are incorporated herein, in their entirety, for all purposes related to this disclosure.
Claims
1. An ultrasound coupling material comprising: a viscosifying agent; and a hydrating fluid comprising at least one multivalent ion.
2. The ultrasound coupling material of claim 1, wherein ultrasound coupling material is a semi-solid.
3. The ultrasound coupling material of claim 1, wherein ultrasound coupling material is a liquid.
4. The ultrasound coupling material of claim 1, wherein ultrasound coupling material is a contiguous mass.
5. The ultrasound coupling material of claim 1, wherein the viscosifying agent comprises an ionically charged polymer.
6. The ultrasound coupling material of claim 1, wherein the viscosifying agent comprises an alginate, polyacrylic acid, polysaccharide, hyaluronic acid or a combination thereof.
7. The ultrasound coupling agent of claim 1, wherein the multivalent ion comprises a divalent ion.
8. The ultrasound coupling agent of claim 1, wherein the multivalent ion comprises calcium.
9. The ultrasound coupling agent of claim 1, wherein the hydrating fluid further comprises an acid.
10. The ultrasound coupling agent of claim 9, wherein the acid comprises citric acid.
1 1. The ultrasound coupling agent of claim 1, wherein the hydrating fluid further comprises an insoluble salt.
12. The ultrasound coupling agent of claim 1 1, wherein the insoluble salt comprises an insoluble calcium salt.
13. The ultrasound coupling agent of claim 1 1, wherein the insoluble salt comprises calcium hydrogen phosphate.
14. The ultrasound coupling material of claim 1, wherein the ultrasound coupling material further comprises a hydrophilic cross-linked polymer.
15. An ultrasound coupling material comprising: sodium alginate; a divalent ion, wherein the divalent ion is calcium; insoluble calcium salt; calcium sequesterant; and a water soluble acid.
16. The ultrasound coupling fluid of claim 15, wherein the insoluble salt comprises calcium hydrogen phosphate, calcium sulfate, dicalcium phosphate anhydrous or a combination thereof.
17. The ultrasound coupling agent of claim 15, wherein the calcium sequesterant comprises sodium pyrophosphate.
18. The ultrasound coupling agent of claim 15, wherein the acid comprises citric acid.
19. The ultrasound coupling agent of claim 15, wherein the ultrasound coupling agent further comprises a calcium sequesterant.
20. The ultrasound coupling agent of claim 19, wherein the calcium sequesterant comprises sodium pyrophosphate.
21. An ultrasound coupling material comprising: a hydrogel; and a hydrating fluid.
22. The ultrasound coupling material of claim 21 , wherein ultrasound coupling material is a semi-solid.
23. The ultrasound coupling material of claim 21, wherein ultrasound coupling material is a liquid.
24. The ultrasound coupling material of claim 21 , wherein ultrasound coupling material is a contiguous mass.
25. The ultrasound coupling material of claim 21, wherein the hydrogel comprises a cross-linked hydrophilic polymer.
26. The ultrasound coupling material of claim 21, wherein the cross-linked hydrophilic polymer comprises polyacrylic acid, polyacrylamide or co-polymers thereof.
27. The ultrasound coupling material of claim 21 , wherein the cross-linked hydrophilic polymer further comprises a plurality of pores.
28. The ultrasound coupling material of claim 27, wherein at least some of the pores are interconnected.
29. The ultrasound coupling material of claim 21 , wherein the ultrasound coupling agent further comprises a surfactant.
30. The ultrasound coupling material of claim 21, wherein the ultrasound coupling agent further comprises a wetting agent.
31. The ultrasound coupling agent of claim 21 , wherein the ultrasound coupling agent further comprises an insoluble salt.
32. The ultrasound coupling agent of claim 31 , wherein the insoluble salt comprises an insoluble calcium salt.
33. The ultrasound coupling agent of claim 31, wherein the insoluble salt comprises calcium hydrogen phosphate.
34. The ultrasound coupling material of claim 21, wherein the hydrating fluid further comprises a viscosifying agent.
35. The ultrasound coupling material of claim 34, wherein the viscosifying agent comprises an ionically charged polymer.
36. The ultrasound coupling material of claim 34, wherein the viscosifying agent comprises an alginate, polyacrylic acid, polysaccharide, hyaluronic acid or a combination thereof.
37. The ultrasound coupling material of claim 21, wherein the hydrating fluid further comprises an acid.
38. An ultrasound coupling material of claim 37, wherein the acid comprises citric acid.
39. The ultrasound coupling material of claim 21, wherein the hydrating fluid further comprises a preservative.
40. The ultrasound coupling material of claim 21, further comprising polymer latex particles.
41. The ultrasound coupling material of claim 40, wherein the polymer latex particles comprise monodispersed, surface-modified polystyrene particles.
42. The ultrasound coupling material of claim 40, wherein the particle size is between 100 nm to 100 μm.
43. An ultrasound coupling material comprising: polyacrylic acid-co-polyacrylamide co-polymer; a surfactant; a calcium salt; citric acid; and a preservative.
44. The ultrasound coupling material of claim 43, wherein the calcium salt comprises dicalcium phosphate anhydrous.
45. A hydrating fluid comprising: alginate; citric acid; a preservative; and optionally a surfactant.
46. An ultrasound coupling material comprising: polyacrylic acid, polyacrylamide or co-polymers thereof; and a hydrating fluid.
47. A method of making an ultrasound coupling material comprising: providing a cross-linked hydrophilic polymer; introducing a hydrating fluid comprising water to the cross-linked hydrophilic polymer; and forming a semi-solid ultrasound coupling material.
48. A method of making an ultrasound coupling material comprising: providing a viscosifying agent comprising an ionically charged polymer; introducing a hydrating fluid comprising a soluble multivalent ion to the ionically charged polymer; and forming a semi-solid ultrasound coupling material.
49. An ultrasound diagnostic system comprising: a transducer; an applicator dome comprising a first side and a second side, wherein the first side is in communication with the transducer and the second side is contoured to accept a breast; a hydrogel that is capable of being placed in the second side of the applicator; and a hydrating fluid, wherein upon introducing the hydrating fluid to the hydrogel, a semi-solid ultrasound coupling material is formed.
50. An ultrasound diagnostic system comprising: a transducer; an applicator dome comprising a first side and a second side, wherein the first side is in communication with the transducer and the second side is contoured to accept a breast; a viscosifying agent comprising an ionically charged polymer that is capable of being placed in the second size of the applicator; and a hydrating fluid, wherein upon introducing the hydrating fluid to the viscosifying agent, a semi-solid ultrasound coupling material is formed.
51. A kit comprising: a hydrogel; and a hydrating fluid, wherein the hydrating fluid comprises water.
52. The kit of claim 51, wherein air in the voids in the hydrogel have been filled with polyethylene glycol.
53. The kit of claim 51, wherein the hydrogel and the hydrating fluid are packaged in separate containers.
54. A kit comprising: a viscosifying agent comprising a ionically charged polymer; and a hydrating fluid, wherein the hydrating fluid comprises a multivalent ion.
55. The kit of claim 54, wherein the viscosifying agent and the hydrating fluid are packaged in separate containers.
56. An ultrasound coupling materials that is initially a liquid and becomes a semi-solid over a period of time.
57. The ultrasound coupling material of claim 56, wherein the ultrasound coupling material is a contiguous mass.
58. The ultrasound coupling material of claim 56, wherein the period of time is five minutes or less.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94859507P | 2007-07-09 | 2007-07-09 | |
| US60/948,595 | 2007-07-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2009009064A1 true WO2009009064A1 (en) | 2009-01-15 |
Family
ID=40228920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2008/008414 WO2009009064A1 (en) | 2007-07-09 | 2008-07-09 | Ultrasound coupling material |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2009009064A1 (en) |
Cited By (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011018624A1 (en) * | 2009-08-13 | 2011-02-17 | Smith & Nephew Plc | Ultrasound couplant |
| WO2011096174A1 (en) * | 2010-02-02 | 2011-08-11 | Canon Kabushiki Kaisha | Measuring apparatus |
| WO2012093650A1 (en) * | 2011-01-07 | 2012-07-12 | Canon Kabushiki Kaisha | Measuring apparatus |
| EP2540322A1 (en) * | 2011-07-01 | 2013-01-02 | angioclinic AG | Ultrasonic couplant spray |
| US8388546B2 (en) | 2006-10-23 | 2013-03-05 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
| US8388541B2 (en) | 2007-11-26 | 2013-03-05 | C. R. Bard, Inc. | Integrated system for intravascular placement of a catheter |
| US8437833B2 (en) | 2008-10-07 | 2013-05-07 | Bard Access Systems, Inc. | Percutaneous magnetic gastrostomy |
| US8478382B2 (en) | 2008-02-11 | 2013-07-02 | C. R. Bard, Inc. | Systems and methods for positioning a catheter |
| US8512256B2 (en) | 2006-10-23 | 2013-08-20 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
| USD699359S1 (en) | 2011-08-09 | 2014-02-11 | C. R. Bard, Inc. | Ultrasound probe head |
| US8781555B2 (en) | 2007-11-26 | 2014-07-15 | C. R. Bard, Inc. | System for placement of a catheter including a signal-generating stylet |
| US8784336B2 (en) | 2005-08-24 | 2014-07-22 | C. R. Bard, Inc. | Stylet apparatuses and methods of manufacture |
| US8801693B2 (en) | 2010-10-29 | 2014-08-12 | C. R. Bard, Inc. | Bioimpedance-assisted placement of a medical device |
| US8849382B2 (en) | 2007-11-26 | 2014-09-30 | C. R. Bard, Inc. | Apparatus and display methods relating to intravascular placement of a catheter |
| US9125578B2 (en) | 2009-06-12 | 2015-09-08 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation and tip location |
| US9211107B2 (en) | 2011-11-07 | 2015-12-15 | C. R. Bard, Inc. | Ruggedized ultrasound hydrogel insert |
| US9339206B2 (en) | 2009-06-12 | 2016-05-17 | Bard Access Systems, Inc. | Adaptor for endovascular electrocardiography |
| US9445734B2 (en) | 2009-06-12 | 2016-09-20 | Bard Access Systems, Inc. | Devices and methods for endovascular electrography |
| US9456766B2 (en) | 2007-11-26 | 2016-10-04 | C. R. Bard, Inc. | Apparatus for use with needle insertion guidance system |
| US9492097B2 (en) | 2007-11-26 | 2016-11-15 | C. R. Bard, Inc. | Needle length determination and calibration for insertion guidance system |
| US9521961B2 (en) | 2007-11-26 | 2016-12-20 | C. R. Bard, Inc. | Systems and methods for guiding a medical instrument |
| US9532724B2 (en) | 2009-06-12 | 2017-01-03 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation using endovascular energy mapping |
| US9554716B2 (en) | 2007-11-26 | 2017-01-31 | C. R. Bard, Inc. | Insertion guidance system for needles and medical components |
| US9636031B2 (en) | 2007-11-26 | 2017-05-02 | C.R. Bard, Inc. | Stylets for use with apparatus for intravascular placement of a catheter |
| US9649048B2 (en) | 2007-11-26 | 2017-05-16 | C. R. Bard, Inc. | Systems and methods for breaching a sterile field for intravascular placement of a catheter |
| US9839372B2 (en) | 2014-02-06 | 2017-12-12 | C. R. Bard, Inc. | Systems and methods for guidance and placement of an intravascular device |
| US9901714B2 (en) | 2008-08-22 | 2018-02-27 | C. R. Bard, Inc. | Catheter assembly including ECG sensor and magnetic assemblies |
| US10046139B2 (en) | 2010-08-20 | 2018-08-14 | C. R. Bard, Inc. | Reconfirmation of ECG-assisted catheter tip placement |
| US10349890B2 (en) | 2015-06-26 | 2019-07-16 | C. R. Bard, Inc. | Connector interface for ECG-based catheter positioning system |
| US10449330B2 (en) | 2007-11-26 | 2019-10-22 | C. R. Bard, Inc. | Magnetic element-equipped needle assemblies |
| US10507008B2 (en) | 2015-01-08 | 2019-12-17 | Casey K. Scully | Ultrasound probe couplers and related methods |
| US10524691B2 (en) | 2007-11-26 | 2020-01-07 | C. R. Bard, Inc. | Needle assembly including an aligned magnetic element |
| US10639008B2 (en) | 2009-10-08 | 2020-05-05 | C. R. Bard, Inc. | Support and cover structures for an ultrasound probe head |
| US10743838B2 (en) | 2015-02-25 | 2020-08-18 | Decision Sciences Medical Company, LLC | Acoustic signal transmission couplants and coupling mediums |
| US10751509B2 (en) | 2007-11-26 | 2020-08-25 | C. R. Bard, Inc. | Iconic representations for guidance of an indwelling medical device |
| US10820885B2 (en) | 2012-06-15 | 2020-11-03 | C. R. Bard, Inc. | Apparatus and methods for detection of a removable cap on an ultrasound probe |
| US10888504B2 (en) | 2012-10-15 | 2021-01-12 | L'oreal | Hair styling compositions containing aqueous wax dispersions |
| US10973584B2 (en) | 2015-01-19 | 2021-04-13 | Bard Access Systems, Inc. | Device and method for vascular access |
| US10980510B2 (en) | 2015-01-08 | 2021-04-20 | Casey K. Scully | Ultrasound probe couplers and related methods |
| US10992079B2 (en) | 2018-10-16 | 2021-04-27 | Bard Access Systems, Inc. | Safety-equipped connection systems and methods thereof for establishing electrical connections |
| US10993699B2 (en) | 2011-10-28 | 2021-05-04 | Decision Sciences International Corporation | Spread spectrum coded waveforms in ultrasound diagnostics |
| US11000207B2 (en) | 2016-01-29 | 2021-05-11 | C. R. Bard, Inc. | Multiple coil system for tracking a medical device |
| US11096661B2 (en) | 2013-09-13 | 2021-08-24 | Decision Sciences International Corporation | Coherent spread-spectrum coded waveforms in synthetic aperture image formation |
| US11103213B2 (en) | 2009-10-08 | 2021-08-31 | C. R. Bard, Inc. | Spacers for use with an ultrasound probe |
| US11154274B2 (en) | 2019-04-23 | 2021-10-26 | Decision Sciences Medical Company, LLC | Semi-rigid acoustic coupling articles for ultrasound diagnostic and treatment applications |
| CN115040666A (en) * | 2021-10-13 | 2022-09-13 | 深圳市华宝生物材料科技有限公司 | Medical ultrasonic coupling agent and preparation method thereof |
| US11520043B2 (en) | 2020-11-13 | 2022-12-06 | Decision Sciences Medical Company, LLC | Systems and methods for synthetic aperture ultrasound imaging of an object |
| CN116472311A (en) * | 2020-11-04 | 2023-07-21 | 赫尔穆特·哈斯 | Contact medium |
| US11737726B2 (en) | 2015-10-08 | 2023-08-29 | Decision Sciences Medical Company, LLC | Acoustic orthopedic tracking system and methods |
| US12017389B2 (en) | 2019-03-06 | 2024-06-25 | Decision Sciences Medical Company, LLC | Methods for manufacturing and distributing semi-rigid acoustic coupling articles and packaging for ultrasound imaging |
| US20240307032A1 (en) * | 2017-04-27 | 2024-09-19 | Civco Medical Instruments Co., Inc. | Sterile covers for ultrasound transducer |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4782946A (en) * | 1987-09-17 | 1988-11-08 | Allergan, Inc. | Soft contact lens hydration device and kit |
| US5596084A (en) * | 1994-10-05 | 1997-01-21 | Monsanto Company | Alginate gels |
| US5919742A (en) * | 1996-07-29 | 1999-07-06 | Menicon Co., Ltd. | Contact lens cleaning material formed of a polymer |
| US20040115271A1 (en) * | 2002-06-21 | 2004-06-17 | Alex Sacharoff | Hydration compositions for corneal pre-surgery treatment |
| US20050095296A1 (en) * | 2003-11-05 | 2005-05-05 | Lowman Anthony M. | Hydrogel compositions and manufacturing process for ultrasound couplants |
| US20050112135A1 (en) * | 2003-11-21 | 2005-05-26 | Cormier Michel J. | Ultrasound assisted transdermal vaccine delivery method and system |
| US7001355B2 (en) * | 2002-01-21 | 2006-02-21 | The Procter & Gamble Company | Skin care device |
| US7033603B2 (en) * | 1999-08-06 | 2006-04-25 | Board Of Regents The University Of Texas | Drug releasing biodegradable fiber for delivery of therapeutics |
| US20060165607A1 (en) * | 2002-07-05 | 2006-07-27 | Masaya Tanaka | Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
| US20060246111A1 (en) * | 2005-04-19 | 2006-11-02 | Smith Larry L | Polysaccharides as ultrasound transmission media |
-
2008
- 2008-07-09 WO PCT/US2008/008414 patent/WO2009009064A1/en active Application Filing
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4782946A (en) * | 1987-09-17 | 1988-11-08 | Allergan, Inc. | Soft contact lens hydration device and kit |
| US5596084A (en) * | 1994-10-05 | 1997-01-21 | Monsanto Company | Alginate gels |
| US5919742A (en) * | 1996-07-29 | 1999-07-06 | Menicon Co., Ltd. | Contact lens cleaning material formed of a polymer |
| US7033603B2 (en) * | 1999-08-06 | 2006-04-25 | Board Of Regents The University Of Texas | Drug releasing biodegradable fiber for delivery of therapeutics |
| US7001355B2 (en) * | 2002-01-21 | 2006-02-21 | The Procter & Gamble Company | Skin care device |
| US20040115271A1 (en) * | 2002-06-21 | 2004-06-17 | Alex Sacharoff | Hydration compositions for corneal pre-surgery treatment |
| US20060165607A1 (en) * | 2002-07-05 | 2006-07-27 | Masaya Tanaka | Carbon dioxide external preparation and material for formation of carbon dioxide external preparation |
| US20050095296A1 (en) * | 2003-11-05 | 2005-05-05 | Lowman Anthony M. | Hydrogel compositions and manufacturing process for ultrasound couplants |
| US20050112135A1 (en) * | 2003-11-21 | 2005-05-26 | Cormier Michel J. | Ultrasound assisted transdermal vaccine delivery method and system |
| US20060246111A1 (en) * | 2005-04-19 | 2006-11-02 | Smith Larry L | Polysaccharides as ultrasound transmission media |
Cited By (102)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11207496B2 (en) | 2005-08-24 | 2021-12-28 | C. R. Bard, Inc. | Stylet apparatuses and methods of manufacture |
| US10004875B2 (en) | 2005-08-24 | 2018-06-26 | C. R. Bard, Inc. | Stylet apparatuses and methods of manufacture |
| US8784336B2 (en) | 2005-08-24 | 2014-07-22 | C. R. Bard, Inc. | Stylet apparatuses and methods of manufacture |
| US8774907B2 (en) | 2006-10-23 | 2014-07-08 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
| US9833169B2 (en) | 2006-10-23 | 2017-12-05 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
| US9345422B2 (en) | 2006-10-23 | 2016-05-24 | Bard Acess Systems, Inc. | Method of locating the tip of a central venous catheter |
| US8388546B2 (en) | 2006-10-23 | 2013-03-05 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
| US9265443B2 (en) | 2006-10-23 | 2016-02-23 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
| US8858455B2 (en) | 2006-10-23 | 2014-10-14 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
| US8512256B2 (en) | 2006-10-23 | 2013-08-20 | Bard Access Systems, Inc. | Method of locating the tip of a central venous catheter |
| US11134915B2 (en) | 2007-11-26 | 2021-10-05 | C. R. Bard, Inc. | System for placement of a catheter including a signal-generating stylet |
| US10165962B2 (en) | 2007-11-26 | 2019-01-01 | C. R. Bard, Inc. | Integrated systems for intravascular placement of a catheter |
| US11779240B2 (en) | 2007-11-26 | 2023-10-10 | C. R. Bard, Inc. | Systems and methods for breaching a sterile field for intravascular placement of a catheter |
| US8781555B2 (en) | 2007-11-26 | 2014-07-15 | C. R. Bard, Inc. | System for placement of a catheter including a signal-generating stylet |
| US11707205B2 (en) | 2007-11-26 | 2023-07-25 | C. R. Bard, Inc. | Integrated system for intravascular placement of a catheter |
| US11529070B2 (en) | 2007-11-26 | 2022-12-20 | C. R. Bard, Inc. | System and methods for guiding a medical instrument |
| US8849382B2 (en) | 2007-11-26 | 2014-09-30 | C. R. Bard, Inc. | Apparatus and display methods relating to intravascular placement of a catheter |
| US11123099B2 (en) | 2007-11-26 | 2021-09-21 | C. R. Bard, Inc. | Apparatus for use with needle insertion guidance system |
| US10524691B2 (en) | 2007-11-26 | 2020-01-07 | C. R. Bard, Inc. | Needle assembly including an aligned magnetic element |
| US10849695B2 (en) | 2007-11-26 | 2020-12-01 | C. R. Bard, Inc. | Systems and methods for breaching a sterile field for intravascular placement of a catheter |
| US10751509B2 (en) | 2007-11-26 | 2020-08-25 | C. R. Bard, Inc. | Iconic representations for guidance of an indwelling medical device |
| US8388541B2 (en) | 2007-11-26 | 2013-03-05 | C. R. Bard, Inc. | Integrated system for intravascular placement of a catheter |
| US10966630B2 (en) | 2007-11-26 | 2021-04-06 | C. R. Bard, Inc. | Integrated system for intravascular placement of a catheter |
| US10449330B2 (en) | 2007-11-26 | 2019-10-22 | C. R. Bard, Inc. | Magnetic element-equipped needle assemblies |
| US10342575B2 (en) | 2007-11-26 | 2019-07-09 | C. R. Bard, Inc. | Apparatus for use with needle insertion guidance system |
| US10238418B2 (en) | 2007-11-26 | 2019-03-26 | C. R. Bard, Inc. | Apparatus for use with needle insertion guidance system |
| US10231753B2 (en) | 2007-11-26 | 2019-03-19 | C. R. Bard, Inc. | Insertion guidance system for needles and medical components |
| US10602958B2 (en) | 2007-11-26 | 2020-03-31 | C. R. Bard, Inc. | Systems and methods for guiding a medical instrument |
| US9456766B2 (en) | 2007-11-26 | 2016-10-04 | C. R. Bard, Inc. | Apparatus for use with needle insertion guidance system |
| US9492097B2 (en) | 2007-11-26 | 2016-11-15 | C. R. Bard, Inc. | Needle length determination and calibration for insertion guidance system |
| US9521961B2 (en) | 2007-11-26 | 2016-12-20 | C. R. Bard, Inc. | Systems and methods for guiding a medical instrument |
| US9526440B2 (en) | 2007-11-26 | 2016-12-27 | C.R. Bard, Inc. | System for placement of a catheter including a signal-generating stylet |
| US10105121B2 (en) | 2007-11-26 | 2018-10-23 | C. R. Bard, Inc. | System for placement of a catheter including a signal-generating stylet |
| US9549685B2 (en) | 2007-11-26 | 2017-01-24 | C. R. Bard, Inc. | Apparatus and display methods relating to intravascular placement of a catheter |
| US9554716B2 (en) | 2007-11-26 | 2017-01-31 | C. R. Bard, Inc. | Insertion guidance system for needles and medical components |
| US9636031B2 (en) | 2007-11-26 | 2017-05-02 | C.R. Bard, Inc. | Stylets for use with apparatus for intravascular placement of a catheter |
| US9649048B2 (en) | 2007-11-26 | 2017-05-16 | C. R. Bard, Inc. | Systems and methods for breaching a sterile field for intravascular placement of a catheter |
| US9681823B2 (en) | 2007-11-26 | 2017-06-20 | C. R. Bard, Inc. | Integrated system for intravascular placement of a catheter |
| US9999371B2 (en) | 2007-11-26 | 2018-06-19 | C. R. Bard, Inc. | Integrated system for intravascular placement of a catheter |
| US8478382B2 (en) | 2008-02-11 | 2013-07-02 | C. R. Bard, Inc. | Systems and methods for positioning a catheter |
| US8971994B2 (en) | 2008-02-11 | 2015-03-03 | C. R. Bard, Inc. | Systems and methods for positioning a catheter |
| US9901714B2 (en) | 2008-08-22 | 2018-02-27 | C. R. Bard, Inc. | Catheter assembly including ECG sensor and magnetic assemblies |
| US11027101B2 (en) | 2008-08-22 | 2021-06-08 | C. R. Bard, Inc. | Catheter assembly including ECG sensor and magnetic assemblies |
| US9907513B2 (en) | 2008-10-07 | 2018-03-06 | Bard Access Systems, Inc. | Percutaneous magnetic gastrostomy |
| US8437833B2 (en) | 2008-10-07 | 2013-05-07 | Bard Access Systems, Inc. | Percutaneous magnetic gastrostomy |
| US11419517B2 (en) | 2009-06-12 | 2022-08-23 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation using endovascular energy mapping |
| US9125578B2 (en) | 2009-06-12 | 2015-09-08 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation and tip location |
| US10912488B2 (en) | 2009-06-12 | 2021-02-09 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation and tip location |
| US10231643B2 (en) | 2009-06-12 | 2019-03-19 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation and tip location |
| US9445734B2 (en) | 2009-06-12 | 2016-09-20 | Bard Access Systems, Inc. | Devices and methods for endovascular electrography |
| US10271762B2 (en) | 2009-06-12 | 2019-04-30 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation using endovascular energy mapping |
| US9339206B2 (en) | 2009-06-12 | 2016-05-17 | Bard Access Systems, Inc. | Adaptor for endovascular electrocardiography |
| US9532724B2 (en) | 2009-06-12 | 2017-01-03 | Bard Access Systems, Inc. | Apparatus and method for catheter navigation using endovascular energy mapping |
| WO2011018624A1 (en) * | 2009-08-13 | 2011-02-17 | Smith & Nephew Plc | Ultrasound couplant |
| US11103213B2 (en) | 2009-10-08 | 2021-08-31 | C. R. Bard, Inc. | Spacers for use with an ultrasound probe |
| US11998386B2 (en) | 2009-10-08 | 2024-06-04 | C. R. Bard, Inc. | Support and cover structures for an ultrasound probe head |
| US10639008B2 (en) | 2009-10-08 | 2020-05-05 | C. R. Bard, Inc. | Support and cover structures for an ultrasound probe head |
| WO2011096174A1 (en) * | 2010-02-02 | 2011-08-11 | Canon Kabushiki Kaisha | Measuring apparatus |
| US9271695B2 (en) | 2010-02-02 | 2016-03-01 | Canon Kabushiki Kaisha | Apparatus for mammography with acoustic matching |
| US10046139B2 (en) | 2010-08-20 | 2018-08-14 | C. R. Bard, Inc. | Reconfirmation of ECG-assisted catheter tip placement |
| US8801693B2 (en) | 2010-10-29 | 2014-08-12 | C. R. Bard, Inc. | Bioimpedance-assisted placement of a medical device |
| US9415188B2 (en) | 2010-10-29 | 2016-08-16 | C. R. Bard, Inc. | Bioimpedance-assisted placement of a medical device |
| WO2012093650A1 (en) * | 2011-01-07 | 2012-07-12 | Canon Kabushiki Kaisha | Measuring apparatus |
| CN103313649A (en) * | 2011-01-07 | 2013-09-18 | 佳能株式会社 | Measuring apparatus |
| US11311635B2 (en) | 2011-07-01 | 2022-04-26 | Angioclinic Ag | Ultrasonic couplant spray |
| WO2013004518A1 (en) * | 2011-07-01 | 2013-01-10 | Angioclinic Ag | Ultrasonic couplant spray |
| EP2540322A1 (en) * | 2011-07-01 | 2013-01-02 | angioclinic AG | Ultrasonic couplant spray |
| USD754357S1 (en) | 2011-08-09 | 2016-04-19 | C. R. Bard, Inc. | Ultrasound probe head |
| USD699359S1 (en) | 2011-08-09 | 2014-02-11 | C. R. Bard, Inc. | Ultrasound probe head |
| US11596388B2 (en) | 2011-10-28 | 2023-03-07 | Decision Sciences International Corporation | Spread spectrum coded waveforms in ultrasound diagnostics |
| US10993699B2 (en) | 2011-10-28 | 2021-05-04 | Decision Sciences International Corporation | Spread spectrum coded waveforms in ultrasound diagnostics |
| US11957516B2 (en) | 2011-10-28 | 2024-04-16 | Decision Sciences International Corporation | Spread spectrum coded waveforms in ultrasound diagnostics |
| US9211107B2 (en) | 2011-11-07 | 2015-12-15 | C. R. Bard, Inc. | Ruggedized ultrasound hydrogel insert |
| US10820885B2 (en) | 2012-06-15 | 2020-11-03 | C. R. Bard, Inc. | Apparatus and methods for detection of a removable cap on an ultrasound probe |
| US10888504B2 (en) | 2012-10-15 | 2021-01-12 | L'oreal | Hair styling compositions containing aqueous wax dispersions |
| US11607192B2 (en) | 2013-09-13 | 2023-03-21 | Decision Sciences International Corporation | Coherent spread-spectrum coded waveforms in synthetic aperture image formation |
| US12121394B2 (en) | 2013-09-13 | 2024-10-22 | Decision Sciences International Corporation | Coherent spread-spectrum coded waveforms in synthetic aperture image formation |
| US11096661B2 (en) | 2013-09-13 | 2021-08-24 | Decision Sciences International Corporation | Coherent spread-spectrum coded waveforms in synthetic aperture image formation |
| US10863920B2 (en) | 2014-02-06 | 2020-12-15 | C. R. Bard, Inc. | Systems and methods for guidance and placement of an intravascular device |
| US9839372B2 (en) | 2014-02-06 | 2017-12-12 | C. R. Bard, Inc. | Systems and methods for guidance and placement of an intravascular device |
| US10507008B2 (en) | 2015-01-08 | 2019-12-17 | Casey K. Scully | Ultrasound probe couplers and related methods |
| US10980510B2 (en) | 2015-01-08 | 2021-04-20 | Casey K. Scully | Ultrasound probe couplers and related methods |
| US10973584B2 (en) | 2015-01-19 | 2021-04-13 | Bard Access Systems, Inc. | Device and method for vascular access |
| US11191521B2 (en) | 2015-02-25 | 2021-12-07 | Decision Sciences Medical Company, LLC | Acoustic signal transmission couplants and coupling mediums |
| US11839512B2 (en) | 2015-02-25 | 2023-12-12 | Decision Sciences Medical Company, LLC | Acoustic signal transmission couplants and coupling mediums |
| US10743838B2 (en) | 2015-02-25 | 2020-08-18 | Decision Sciences Medical Company, LLC | Acoustic signal transmission couplants and coupling mediums |
| US11026630B2 (en) | 2015-06-26 | 2021-06-08 | C. R. Bard, Inc. | Connector interface for ECG-based catheter positioning system |
| US10349890B2 (en) | 2015-06-26 | 2019-07-16 | C. R. Bard, Inc. | Connector interface for ECG-based catheter positioning system |
| US11737726B2 (en) | 2015-10-08 | 2023-08-29 | Decision Sciences Medical Company, LLC | Acoustic orthopedic tracking system and methods |
| US12251259B2 (en) | 2015-10-08 | 2025-03-18 | Decision Sciences Medical Company, LLC | Acoustic orthopedic tracking system and methods |
| US11000207B2 (en) | 2016-01-29 | 2021-05-11 | C. R. Bard, Inc. | Multiple coil system for tracking a medical device |
| US20240307031A1 (en) * | 2017-04-27 | 2024-09-19 | Civco Medical Instruments Co., Inc. | Sterile covers for ultrasound transducer |
| US20240307032A1 (en) * | 2017-04-27 | 2024-09-19 | Civco Medical Instruments Co., Inc. | Sterile covers for ultrasound transducer |
| US11621518B2 (en) | 2018-10-16 | 2023-04-04 | Bard Access Systems, Inc. | Safety-equipped connection systems and methods thereof for establishing electrical connections |
| US10992079B2 (en) | 2018-10-16 | 2021-04-27 | Bard Access Systems, Inc. | Safety-equipped connection systems and methods thereof for establishing electrical connections |
| US12017389B2 (en) | 2019-03-06 | 2024-06-25 | Decision Sciences Medical Company, LLC | Methods for manufacturing and distributing semi-rigid acoustic coupling articles and packaging for ultrasound imaging |
| US11154274B2 (en) | 2019-04-23 | 2021-10-26 | Decision Sciences Medical Company, LLC | Semi-rigid acoustic coupling articles for ultrasound diagnostic and treatment applications |
| CN116472311A (en) * | 2020-11-04 | 2023-07-21 | 赫尔穆特·哈斯 | Contact medium |
| US11520043B2 (en) | 2020-11-13 | 2022-12-06 | Decision Sciences Medical Company, LLC | Systems and methods for synthetic aperture ultrasound imaging of an object |
| US12320893B2 (en) | 2020-11-13 | 2025-06-03 | Decision Sciences Medical Company, LLC | Systems and methods for synthetic aperture ultrasound imaging of an object |
| CN115040666B (en) * | 2021-10-13 | 2023-07-28 | 深圳市华宝生物材料科技有限公司 | Medical ultrasonic coupling agent and preparation method thereof |
| CN115040666A (en) * | 2021-10-13 | 2022-09-13 | 深圳市华宝生物材料科技有限公司 | Medical ultrasonic coupling agent and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2009009064A1 (en) | Ultrasound coupling material | |
| AU627456B2 (en) | Ultrasonic contrast medium made up of small gas bubbles and fatty-acid-containing microparticles | |
| FI81264B (en) | MICROPARTICLAR OCH GASBLAOSOR INNEHAOLLANDE ULTRALJUDCONTRASTMELEL | |
| EP0077752B2 (en) | Liquid mixture for absorbing and stabilizing gas bubbles to be used as contrast agent in ultrasonic diagnosis and process for its preparation | |
| KR100478227B1 (en) | Preparing method for embolic materials comprising of chitin and/or chitosan | |
| CA2487796A1 (en) | Implantable product with improved aqueous interface characteristics and method for making and using same | |
| JPH08509141A (en) | Medical devices and materials that enhance the visibility of magnetic images | |
| IE57197B1 (en) | Ultrasound contrast agent containing microparticles and gas micro-bubbles | |
| EP0628284B1 (en) | Contact medium for probe of ultrasonic diagnostic apparatus | |
| CN105147723B (en) | A kind of thermo-sensitive gel preparation, its preparation method and its prevented in lithotrity calculus shift in application | |
| KR101725311B1 (en) | Water-soluble hydrogel pads composite of the ultrasonic inspection purposes and its production method | |
| US9259494B2 (en) | Composition and method for medical imaging of body cavities | |
| Donnermeyer et al. | Comparative analysis of irrigation techniques for cleaning efficiency in isthmus structures | |
| US6306366B1 (en) | Microparticles that contain gas, galactose and a saturated fatty acid | |
| EP3636253A1 (en) | Seamless capsule coating composition and seamless capsule | |
| KR20220096510A (en) | Ultrasonic gel pads | |
| CN110584705B (en) | Four-dimensional color ultrasonic machine | |
| WO2024051474A1 (en) | Lipid microbubble lyophilized powder composition and preparation method therefor | |
| KR101804130B1 (en) | Gel pad for ultrasonic wave | |
| JP2005194200A (en) | Cosmetics | |
| JP3174400B2 (en) | Peritoneal washings | |
| WO2005039750A1 (en) | Novel microparticles for ultrasound contrast imaging and drug delivery | |
| JP7211699B2 (en) | Ultrasound contrast agent | |
| RU2225729C1 (en) | Gel for carrying out ultrasonic examination | |
| US4073833A (en) | Encapsulation process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08780059 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A) DATED 18.03.10. |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 08780059 Country of ref document: EP Kind code of ref document: A1 |